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AA(aa)  Amino acid 
ARF  ADP-ribosylation factor 
ATP  Adenosine tri-phosphate 
BCA  Bicinchonic acid 
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EDTA  Ethylendiaminetetraacetic acid 
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GTP  Guanosine triphospahte 
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IF  Immunofluorescence 
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 vi
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PR  Plant Pathogenesis-related 
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SDS-PAGE Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
SNARE Soluble N-ethylmaleimide sensitive factor attachment protein receptor 
TCA  Trichloroacetic acid 
TEMED N, N, N’, N’-Tetramethylethylenediamine 
v-ATPase vacuolar ATPase 
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Abstract 
 
During the characterization of lipid-enriched microdomains at the Golgi (GICs) 
(Gkantiragas, I. et al. 2001), a protein with an apparent molecular mass of 17 
kDa was identified. Cloning and preliminary biochemical characterization 
identified a novel protein, GAPR-1, belonging to the superfamily of PR proteins. 
Based on the primary amino acidic sequence of this protein, some potentially 
interesting characteristics were identified. It contains a consensus sequence for 
myristoylation, a putative caveolin-binding domain, a coiled-coil structure, and an 
isolelectric point (pI) of 9.4, suggesting that GAPR-1 is a highly hydrophilic 
protein (Eberle, H. B. et al. 2002).  
In this thesis, this structural information, was used to i) study the interaction of 
GAPR-1 with membranes, ii) to obtain structural information on the protein, and 
iii) to identify proteins that interact with GAPR-1.GAPR-1 was shown to be 
myristoylated and to interact with Caveolin-1. Myristoylation, together with 
protein-protein or electrostatic interactions at physiological pH could explain its 
strong membrane association. The crystal structure of GAPR-1 showed strong 
structural similarities to other plant pathogenesis-related proteins. Substitution of 
the most conserved amino acids in GAPR-1 (His54, Glu65, Glu86 and His103) in 
the putative active center changed the protein behavior in solution. Size 
exclusion chromatography revealed that the major population of GAPR-1 mutant 
migrated as a dimer, whereas GAPR-1 wild type behaves predominantly as a 
monomer. The tendency of GAPR-1 to form dimers was confirmed by crosslink 
experiments and by the yeast two hybrid system. By affinity chromatography, 
GAPR-1 was shown to interact with three proteins: Nucleolin, Template activating 
factor α (TAFIα) and HSAPRIL. In the yeast two hybrid system, the interaction of 
GARP-1 with Nucleolin was confirmed and shown to be dependent on the most 
conserved amino acid residues in GAPR-1. The interaction between GAPR-1 
and Nucleolin may represent a new mechanism of regulation of innate immunity 
in mammalian cells. 
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 Introduction 
Cell membranes are dynamic and fluid structures and their molecules are able 
to move in the plane of the membrane. A membrane provides a two-
dimensional fluid support for proteins as well as a hydrophobic barrier to 
separate compartments. It is believed that a cell or plasma membrane similar 
to those of today's cells defined the boundary of the first cell nearly 4 billion 
years ago. Since then, cells have evolved in such a way that the plasma 
membrane and intracellular membranes now perform many functions: as a 
barrier to keep the contents of the cell together, allowing nutrients to pass in 
but keeping out many harmful substances; as a signaling platform to relay 
information about the surroundings of the cell to the inside and vice versa; as 
a scaffold to provide places where enzymes can be arranged in an assembly-
line fashion; and as a compartmentalizing structure to separate different parts 
of the cell with different functions.   
 
1 Microdomains in biological membranes 
 
Progress in identifying and characterizing the constituents of membrane 
bound compartments has revealed a distinct level of cellular and sub-cellular 
compartmentation. Proteins and lipids are not uniformly distributed in the 
membrane of a given organelle as domains are formed by a combination of 
hierarchical assembly processes and protein and lipid segregation. This 
implies that membranes should not be considered as a random ocean of lipids 
(Singer, S. J. Nicolson, G. L. 1972), but rather the existence of domain 
structures in the bilayer is acknowledged that impose an organization on the 
distribution of proteins. One of the important features of these domains is that 
the composition and physical properties differ from the overall properties of 
the membrane (Brown, D. 2002). Lipid-based structures within the 
membranes have been designated as lipid microdomains or lipid rafts. These 
heterogeneous structures in membranes were postulated by Simons and van 
Meer (1988). The first experimental evidence for the existence of lipid-
enriched microdomains was obtained by the finding that in non-ionic 
detergents (i.e. Triton X-100) in the cold, certain lipids such as cholesterol and 
sphingolipids are detergent-insoluble. In addition, due to the enrichment of 
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lipids, these detergent-insoluble complexes have a low density as observed 
by flotation experiments in 5-30% linear sucrose gradients (Brown, D. A. 
Rose, J. K. 1992). Thus, the term raft refers to a domain in intact membranes, 
whereas the term detergent-resistant membrane (DRM) refers to the structure 
isolated by detergent insolubility. Due to their presence in the DRMs, many 
proteins are believed to be associated with lipid rafts, e.g. GPI-anchored 
proteins, transmembrane proteins, and dual acylated proteins such as 
tyrosine kinases (Src family) (reviewed in Simons, K. Ikonen, E. 1997). A wide 
variety of detergents other than Triton X-100 have been used to isolate low 
density detergent-insoluble membrane fractions, such as NP40, 
octylglucoside, CHAPs, lubrol and Brij96 (Ilangumaran, S. et al. 1999; Roper, 
K. et al. 2000; Bagnat, M. Simons, K. 2002; Drevot, P. et al. 2002). Detergent-
free preparations of lipid microdomains and microdomain preparations in the 
presence of low TX-100 concentrations have also been reported (Song, K. S. 
et al. 1996).  
 
Lipid rafts or lipid-enriched microdomains can be defined as subdomains of 
the plasma membrane, containing high concentrations of cholesterol and 
sphingolipids (sphingomyelin and glycosphingolipids). In these domains, 
cholesterol condenses the packing of sphingolipid molecules by occupying the 
spaces between the saturated chains. Thus, a separate liquid-ordered phase 
(lo) is formed, which is dispersed in the liquid disordered phase (lc), the latter 
representing a freely packed fluid matrix of the membrane (Fig. 1). How the 
exoplasmic arrangement of sphingolipids and cholesterol is linked to the 
underlying cytoplasmic leaflet is currently not known. Lipid rafts incorporate 
distinct classes of proteins (Brown, D. A. London, E. 1998), such as 
glycosylphosphatidylinositol (GPI)-anchored proteins, dual acylated peripheral 
membrane proteins, cholesterol-linked proteins (Caveolin), and selected 
transmembrane proteins (Fig.1). Little is known about the targeting of proteins 
to lipid-enriched microdomains. A number of these proteins containing a 
combination of covalently attached fatty acids (myristate and palmitate) at 
their N-termini (Galbiati, F. et al. 1999b; Melkonian, K. et al. 1999; van’t Hof, 
W. Resh, M. 1997). This suggests that two saturated acyl chain can cause 
partitioning of proteins into lipid microdomains. Other reports show that a 
single prenyl group or myristate group alone can be sufficient to target a 
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protein to lipid microdomains (Song, K. S. et al. 1996). In these cases, N-
terminal acylation, coupled with protein-protein interactions or protein-lipid 
interactions, can cause partitioning of a protein to DRMs (McCabe, J. B. 
Berthiaume, L. G. 2001).  
 
While there is abundant evidence that such microdomains exist and that they 
perform important functions, it has proven very difficult to obtain experimental 
evidence for their existence in vivo, including a description of their properties 
in terms of size, composition and dynamics. As mentioned above, the 
existence of different types of membrane (micro)domains adds to the difficulty 
in understanding their properties. For instance, Caveolae are one type of 
microdomain at the plasma membrane (Fig. 1). They are small (50-70nm in 
diameter) flask-shaped invaginations with an abundant membrane protein, 
Caveolin, associated with their structures (Kurzchalia, T. V. Parton, R. G. 
1999). Caveolae can also be flat within the plane of the membrane, or be 
present as vesicles.  These structures are cholesterol-rich, and when cells are 
treated in the cold with non-ionic detergents (i.e. Triton X-100), caveolae 
resist detergent-solubilization and can be recovered in low-density fractions 
on density gradients. Caveolae are enriched in molecules that play crucial 
roles in intracellular signal transduction. These molecules include the 
heterotrimeric G proteins, receptor tyrosine kinases, components of the MAP 
kinases pathway, and nitric oxide synthase (reviewed in Smart, E. et al. 
1999). As a consequence, caveolae function as preassembled signaling 
complexes or chemical relays for integrating signal transduction. Interestingly, 
caveolae are only a minor fraction within DRMs (Kurzchalia, T. V. Parton, R. 
G. 1999) and the existence of large amounts of non-caveolar 
(glycosphingolipids(GSL)-enriched) domains in the plane of the  membrane 
(Iwabuchi, K. et al. 1998) adds to the complexity of lateral organizations in the 
plasma membrane for complex activities such as signal transduction 
(Anderson, R. 1998)  (Vincent, J. 2003). 
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Figure 1. Model of a lipid-enriched domain at the plasma membrane. (a). A GPI-
anchored protein is attached to the exoplasmic leaflet, and a doubly acylated Src-kinase to 
the cytoplasmic leaflet or a transmembrane protein (HA). Lipids in the raft are shown as red 
and green, and the lipids in the liquid disordered phase as blue. (b) The lipid bilayer in rafts is 
asymmetric with sphingomyelin (red) and glycosphiongolipid (red) enriched in the exoplasmic 
leaflet and phospholipids (green) e.g phophatidylserine and phosphatidylethanolamine. 
Cholesterol (grey) is present in both faces of the membrane filling the space under the head 
groups of sphingolipids (c) Caveolae formed by caveolin molecules making a hairpin lop in 
the membrane, and the interaction with rafts may be mediated by binding of cholesterol and 
acylation of C-terminal cysteines. (Picture taken from Simons, K. and Ikonen, E. 1997). 
 
1.1 Lipid microdomains and signal transduction 
Experimental evidence suggests that there are several different mechanisms 
through which lipid microdomains may control cell signaling. Lipid rafts may 
contain complete signaling pathways that are activated when a receptor or 
other required molecule is recruited into the raft. In this view, rafts serve to co-
localize the prerequisite components, facilitating their interaction and 
supporting signaling. Thus, receptors, coupling factors, effector enzymes and 
substrates would all be co-localized in a single microdomain, and specificity of 
signaling could be enhanced by restricting receptor localization to a particular 
class of microdomains that contains a specific subset of signaling components 
(Cary, L. Cooper, J. 2000). This restriction would limit access of the receptor 
to components of other signaling pathways and prevent non-specific signaling 
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(Langlet, C. et al. 2000 (Oh, P. Schnitzer, J. E. 2001;Prior, I. A. et al. 2001). In 
this model, microdomains could also contain a nearly complete signaling 
pathway that would be activated when a receptor or other require molecule, 
that is normally localized in the non-raft portion of the membranes, is recruited 
to the rafts (Roy, S. et al. 1999). As an alternative how rafts may control cell 
signaling, rafts could also limit signaling, either by physical sequestration of 
signaling components to block non-specific interactions or by suppressing the 
intrinsic activity of signaling proteins present within rafts (Mueller, G. Frick, W. 
1999; Mettouchi, A. et al. 2001). In these scenarios, microdomains may 
provide regulation via compartmentalization of proteins that could otherwise 
interact, leading to unregulated activation of a pathway. Many receptor 
tyrosine kinases including the EGF receptor, the PDGF receptor, and the 
insulin receptor have been reported to control cell signaling by modulating 
their intrinsic activities due to lipid microdomain localization (Mineo, C. et al. 
1996, Anderson, G. 1998). The involvement of lipid rafts in the function of 
proteins has been studied by different approaches such as depleting cells of 
cholesterol. Lipid rafts are held together via interactions between cholesterol 
and sphingolipids and the integrity can be disrupted by treatment with methyl-
β-cyclodextrin that removes cholesterol (Kilsdonk, E. et al. 1995; Pike, L.  
Miller, J. 1998). Cholesterol depletion e.g. impairs the ability of receptor 
tyrosine kinase to signal, diminishes insulin-stimulated phosphorylation of its 
receptor, or affects insulin-stimulated glucose uptake and oxidation (Vainio, S. 
et al. 2002; Parpal, S. et al. 2001).  
1.1.1 Lipid microdomains and their potential role in immune cell 
activation 
 
One of the best described examples on the involvement of lipid rafts in cellular 
signaling processes are T cells. Cells of both the innate and adaptive immune 
systems express a variety of receptors that allow them to respond to the 
presence of foreign macromolecules in a highly discriminating and sensitive 
fashion. Multichain immune recognition receptors (MIRRs) in lymphocytes, for 
instance, are surface receptors formed by the association of immunoglobulin-
like subunits (recognition subunits) and transducing subunits. The TCR, BCR 
and FcεRI are among the best studied MIRRS in terms of signal transduction 
mechanisms (Dykstra, M. et al. 2003). These molecules are activated through 
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phosphorylation by the Src family protein tyrosine kinases such as LcK, Fyn 
or Lyn. Membranes lipid microdomains are enriched in Src proteins (Resh, M. 
D. 1999) and upon activation of Lyn and Lck, engagement of FcεRI (Field, K. 
et al. 1995)  and TCR (Horejsi, V. et al. 1999) in membrane rafts is observed. 
This implies that microdomain location is crucial for downstream signaling 
events. In the case of the TCR, upon ligand engagement, the microdomain-
associated receptor complexes are highly enriched in hyperphosphorylated 
p23 ζ chains (Montixi, C. et al. 1998) and TCR-CD3 associated complexes. 
This supports the idea that MIRRs directly transmit information via membrane 
rafts upon ligation. MIRR signaling in a restricted area of the membrane 
therefore permits a quick and efficient connection to signaling cascades upon 
receptor engagement. Still the implications of protein sequestering into lipid 
rafts are not completely clear. Membrane proteins in the lipid rafts could favor 
the formation and stabilization of supramolecular complexes by e.g. 
sequestering some proteins away from the endocytic pathway. This could 
promote sustained signaling, a mechanism considered of vital importance 
during immune response (Langlet, C. et al. 2000). During the adaptive and 
innate immune response, microdomains could also be involved to establish 
functionally distinct signaling domains during antigen recognition.  
1.2 Membrane domains in the secretory pathway  
 
The primary function of the Golgi apparatus is the stepwise modification and 
sorting of cargo synthesized in the endoplasmic reticulum (ER) and destined 
for different cellular and extracellular locations (Rothman, J., Wieland, F. 
1996). Many hypotheses have been proposed to understand the general 
concept of transport. Golgi anterograde transport may require vesicles, 
tubules and cisternal-mediated transport (reviewed in Marsh, B., and Howell, 
K. 2002). In the case of vesicular transport, a heptameric cytosolic protein 
complex called COPI (coatomer), in conjunction with the GTP binding protein 
ARF1, forms an electron-dense coat on Golgi membranes, facilitating 
membrane budding and fission events associated with Golgi membrane traffic 
(Nickel, W., Wieland, F. 1998). Recruitment of COPI onto Golgi membranes 
requires ARF1, which, like all GTPases, cycles between a GDP-bound, 
inactive, and a GTP-bound, active form. ARF-1-GTP assembles COPI onto 
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Golgi membranes, whereas GTP hydrolysis is thought to trigger membrane 
release of COPI into the cytosol (Donaldson, J. et al. 1992). This makes COPI 
available for repeated cycles of coat assembly and disassembly. ARF1 thus 
operates as a switch to control COPI assembly onto membranes and 
therefore to regulate its function (Rothman, J., Wieland, F. 1996; Helms, J. 
and Rothman, J. 1992; Donaldson, J. G. et al. 1992). The binding of ARF and 
coatomer onto membranes creates a local domain, involved in sorting of 
cargo and budding of vesicles. Coatomer binds to the C-terminal KKXX motif 
of transmembrane proteins that cycle between the Golgi and ER interface 
(Sohn, K. et al. 1996). This carboxyl-terminal peptide functions as ER retrieval 
sequence (Nilsson, T. et al. 1989). By interaction of COPI-subunits with 
cytoplasmic tails of cargo proteins, resident proteins displaying the K(X)KXX-
like sequence are recognized directly by the coat, and sorted into budding 
vesicles which then returns the resident proteins to earlier compartments in 
the pathway. COPI-coats therefore collect cargo into transport vesicles and 
mediate cargo sorting (Cosson, P. Letourneur, F. 1994). In addition to the 
KKXX sequence, many lumenal ER resident proteins contain a carboxyl 
terminal peptide with a KDEL-sequence, which functions also as retrieval 
signal returning lost ER proteins from as far away as the trans-Golgi network. 
Both motifs are capable to retain certain molecules in the ER through constant 
retrieval from post ER compartments.  
 
Many of the proteins going through the Golgi complex become modified by 
the action of enzymes present within the Golgi, followed by the sorting of the 
final product to its final destination. In mammalian cells, the Golgi is 
comprised of a ribbon of flattened stacks of cisternae that are interspersed by 
opening of various sizes, through which tubules project and vesicles can 
move (Ladinsky, M. S. et al. 1999). Proteins enter the stack at one face, the 
cis-Golgi network and eventually exit the stack at the other face, the trans-
Golgi network. It has been recognized that individual cisternae include 
different set of proteins and that the lipid composition changes from one side 
of the Golgi stack to the other. For instance, the cis-Golgi contains the O-
linked oligosaccharide-modification enzyme, N-acetylgalactosamine 
transferase; the medial Golgi contains N-aceylglucosamine transferase I; 
whereas the TGN contains sialyl-transferase. In addition to the segregation of 
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enzyme activities between cisternae, each individual cisterna is segregated 
into domains by the assembly of transport vesicles: vesicles form exclusively 
at the cisternal rims and not in the middle of cisternal structures. The Golgi 
must retain resident proteins in one domain and catalyze vesicle formation in 
another (Warren, G. Malhotra, V. 1998; Shorter, J. Warren, G. 2002). Thus, 
as is postulated for the ER (see below), vesicle formation may represent a 
mechanism by which membrane domains are generated. When an ER 
retention signal is attached onto one of two medial Golgi enzymes, it was 
found that ER retention of one medial Golgi enzyme led to ER accumulation 
of the other untagged  (Nilsson, T. Warren, G. 1994). In contrast, ER retention 
of a trans Golgi enzyme had no effect on the distribution of the medial Golgi 
enzymes (reviewed in Ward, T. H. et al. 2001). This suggests that the two 
medial Golgi enzymes are in domains as well, possibly a Golgi matrix. 
 
A detergent-insoluble Golgi matrix was identified that binds specifically to 
medial-Golgi enzymes and contains the protein GM130  (Shorter, J. Warren, 
G. 2002). GRASP65, a cis-Golgi surface protein required for stacking of Golgi 
cisternae in vitro (Barr, F.  et al. 1997) binds to GM130, and GM130 binds to 
the vesicle docking protein p115 and to Rab1, a GTPases needed for ER to 
Golgi transport. P115 also interact with Rab1 (Nakamura, N. et al. 1997). 
Thus a cis-Golgi matrix, comprised minimally of GRASP65 and GM130, exists 
as an independent unit that can be recognized by vesicle docking and 
tethering machinery constituents (Rab1 and p115). Therefore, these proteins 
represent a mechanism in which the Golgi matrix could play a role for 
incoming vesicles recognizing the compartment at the Golgi and delivering the 
secretory cargoes.   
 
The Golgi apparatus is also the major site of sphingolipid biosynthesis within 
the cell and acts as a buffer between the glycerolipid-rich ER and the 
sterol/sphingolipid-rich plasma membrane (van Meer, G. 1989). In the Golgi a 
gradient of cholesterol exists across the cisternae, with higher levels in the 
trans side (Pagano, R. E. et al. 2000). To explain this gradient, it was 
proposed that cholesterol-rich membrane domains are selectively transported 
forward through the Golgi toward the plasma membrane (Bretscher, M., 
Munro, S. 1993). Lipid rafts could also be involved in maintenance of the 
Introduction 
 10
distinct lipid compositions of the plasma membrane and organelles of the 
secretory pathway that are maintained in the face of membrane traffic in both 
directions (Mukherjee, S. Maxfield, F. 2000).  
 
The importance of membrane microdomains in trafficking (Simons, K. Ikonen, 
E. 1997; Pfeffer, S. 2003) was shown at late stages of the secretory pathway 
and in the endocytic pathway. Membranes of the Golgi, TGN, and endocytic 
pathway can contain significant amounts of cholesterol and sphingolipid that 
may partition in microdomains as observed at the plasma membrane (Brown, 
D. A. London, E. 1998).Sorting of cargo proteins can be coupled to lipid 
sorting if proteins partition preferentially into lipid rafts (Simons, K. Ikonen, E. 
1997). ER to Golgi transport of GPI-anchored proteins, for instance, is 
selectively retarded when sphingolipid synthesis is inhibited (Skrzypek, M. et 
al. 1997), suggesting that lipid microdomains form in the ER and that GPI-
anchored proteins must partition into these domains for efficient transport 
(Sϋtterlin, C. et al. 1997). However, GPI-anchored proteins are detergent-
soluble when present in the ER and only become detergent-insoluble in the 
medial-Golgi during biosynthetic transport (Brown, D. A. London, E. 2000). 
Maybe microdomains in the ER are only held together by weak interactions 
that are disrupted by addition of Triton X-100.  
1.3 Golgi apparatus as a signaling platform 
 
Coatomer and Cdc42 interact at the Golgi apparatus and this interaction 
affects both secretory traffic and cellular growth control. This raises the 
possibility that the Golgi functions as a scaffold for cell signaling (reviewed in 
Donaldson, J. Lippincott-Schwartz, J. 2000). It is likely that mammalian cells 
have exploited Golgi membranes and their unique cellular setting to regulate 
several key cellular processes during evolution. The Golgi is situated between 
the ER and the plasma membrane (PM), at the intersection of a variety of 
membrane trafficking pathways. A variety of signaling molecules associate 
with Golgi membranes, including heterotrimeric G proteins, PI(3)kinase, 
eNOS and Cdc42 (McCalllum, S. et al. 1998; Garcia-Cardena, G. et al. 1997); 
Godi, A. et al. 1999). Golgi membranes also interact with a variety of motor 
and cytoskeletal proteins, including p200/myosin II, myosin I, V, and VI, 
dynein, spectrin, and ankyrin (De Matteis, M. A. Morrow, J. S. 1998) that 
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facilitate the Golgi’s spatial control of membrane traffic but also might help to 
coordinate signaling pathways. 
 
Signaling cascades at the Golgi complex may be regulated by lipid-enriched 
microdomains as well. The presence of such domains at this organelle is 
supported by several lines of evidence. 
 
First, Lipid microdomains have been identified at several organelles along the 
late secretory pathway and endocytic pathway (including endosomes 
(Nichols, B. et al. 2001)), caveosomes (Pelkmans, L. et al. 2001) and  
phagosomes (Dermine, J. F. et al. 2001). Via membrane trafficking pathways, 
the Golgi complex is connected to these organelles and evidence exists that 
also raft components travel between the Golgi and these compartments. 
Proteins such as TGN38 and STxB travel from the plasma membrane to the 
Golgi complex. They are taken up via clathrin-coated pits into transferrin-
positive recycling endosomes and sorted for subsequent delivery to the Golgi 
complex (Gosh, R. et al. 1998; Mallard, F. et al. 1998). The folate receptor, a 
GPI-anchored protein, also recycles via this pathway and the recycling 
efficiency appears to depend on raft partitioning (Mayor, S. et al. 1998). Other 
rafts markers en route to the Golgi are, however, separated from the pathway 
followed by transferrin (Nichols, B. et al. 2001), implying that certain lipid 
microdomains continuously circulate between plasma membrane and Golgi 
pools, possibly via caveosomes.  
 
Second, it has been observed that cholesterol is essential for the biogenesis 
of secretory vesicles from the TGN, suggesting that this process requires the 
formation of lipid rafts (Wang, Y. et al. 2001). At the TGN, assembly of 
glycosphingolipids together with cholesterol into lipid microdomains suggests 
a means of packaging glycosphingolipids into the curved lumenal membrane 
side of secretory vesicles. In this model, lipid rafts coincide with secretory 
vesicle formation, and this has been suggested for the formation of 
constitutive secretory vesicles to the apical membrane (Röper, K. et al. 2000). 
Lipid rafts in the TGN may contribute to the driving force for the formation of 
secretory vesicles.  
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Third, microdomains have been isolated from early Golgi compartments  
(Gkantiragas, I. et al. 2001). These microdomains contain a unique subset of 
proteins and lipids as compared to other membrane rafts. These detergent- 
insoluble complexes in the Golgi have been denominated as GICs (Golgi-
derived detergent-insoluble complexes). Similar to other types of DRMs, it 
reveals an enrichment of sphingolipids and cholesterol. This lipid-scaffold 
seems to be required for GICs integrity (Gkantiragas, I. et al. 2001). 
Interestingly, GIC proteins and lipids are segregated for COPI vesicles, 
suggesting that they are not involved in the budding of COPI-vesicles at the 
early Golgi complex. Since the core complex travels through the early 
secretory pathway, an as yet unknown and distinct mechanism must exist by 
which GICs are transported. The presence in GICs of heterotrimeric G 
proteins (α and β subunits) opens the possibility that these microdomains are 
involved in signal transduction at the Golgi complex.  GICs are composed of 
ten major proteins (Fig. 2): 1) Caveolin-1, which has been implied in 
regulating the function of heterotrimeric G proteins (Okamoto, T. et al. 1998) 
and which localizes predominantly to detergent-resistant complexes at the 
plasma membrane; 2-3) α and β subunits of heterotrimeric G proteins, 
implicated in signal transduction (Moffet, S. B., Deborah; Linder, Maurine. 
2000), membrane fusion (Helms, J.B. et al. 1998) and maintenance of Golgi 
structure (Jamora, C. et al. 1997; Yamaguchi, T. et al. 2000); 4-7) 4 subunits 
of the V1 domain of the vacuolar H+ -ATPase, possibly involved in luminal pH 
regulation by association/dissociation of V1 and V0 subunits and in 
membrane fusion (reviewed in Gkantiragas, I. et al. 2001); 8) Flotillin-1, 
described as a component of DRMs (Volonte, D. et al. 1999) and as a 
component involved in insulin signaling by association with CAP-Cbl complex, 
directing the complex to the plasma membrane microdomain (Christian A. 
Baumann, V. R., Makoto Kanzaki, et al. 2000); 9) GREG (referred to as p45 in 
Gkantiragas, I. et al. 2001), a GPI-anchored protein at the Golgi (Xueyi Li 
unpublished data), and involved in maintenance of the Golgi structure. GREG 
may also be responsible for the structural organization of GICs, and 10) 
GAPR-1. Cloning of GAPR-1 (Eberle, H. B. et al. 2002) allowed its 
classification as a mammalian homologue of plant pathogenesis-related 
proteins (PR proteins). Biochemical characterization revealed some unique 
features not seen for any other family member, such as intracellular 
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localization, myristoylation, membrane localization, and microdomain 
association. Its association to the microdomains and relationship to the 
immune response could help to understand and clarify its role in the cell as 
well as to understand the function of GICs in the Golgi apparatus.   
 
 
Figure 2. Comparison of the protein components of DRM and GICs. GICs and total-DRM 
were isolated from CHO Golgi membranes and total cell lysates, respectively, as described in 
MATERIALS AND METHODS. Proteins were analyzed by SDS-PAGE (12%) gel and stained 
with Coomassie blue. Proteins identified in GICs are shown on  the right (Gkantiragas, I. et al. 
2001). 
 
 
2 Plant pathogens and integrated defence responses to infection 
 
The homology of GAPR-1 to the superfamily of PR proteins, group 1, 
suggests a possible role of GAPR-1 in the immune system. In plants, PR 
proteins have been implied in the immune system, which is reminiscent of the 
innate immune system in mammals. Innate immunity is an ancient form of 
defense against microbial infection that is shared by plants, insects and 
vertebrates. The discrimination of many potential pathogens from self is a 
formidable task for the innate immune system. Many plants respond to local 
attack by pathogens with a production of compounds reducing or inhibiting 
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further attack. Responses occur at the site attacked but also at distal parts. At 
the site of attack, the responses include an oxidative burst, leading to cell 
death. In this way the pathogen is killed and is prevented from spreading from 
the site of initial infection. Further local responses in the surrounding cells 
include changes in cell wall composition, de novo synthesis of phytoalexins 
and pathogenesis-related proteins (PR). PR proteins were detected and 
defined as being absent in healthy plants but accumulating in large amount 
after infection (Heil, M. Bostock, R. M. 2002). More than 17 protein families 
have been assigned to this superfamily of proteins 
(http://www.bio.uu.nl/~fytopath/PR-families.htm). PR-1 proteins play a central 
role in the defense system in plants during the manifestation of systemic 
acquired resistance (SAR). Fig. 3 shows the NMR structure of one member of 
the PR-1 group, p14a tomato, which exhibits a 35% amino acid sequence 
identity with the human glioma pathogenesis-related protein (GliPR). 
Comparison of both proteins led to the identification of a common, partially 
solvent-exposed cluster of four amino acid residues in GLiPR-1 (His69, 
Glu88, Glu110, and His127) that is well conserved in all known plant PR 
proteins group 1 (Szyperski, T. et al. 1998). This could indicate the existence 
of a common active site for these proteins. In P14a, due to the arrangement of 
the amino acid residues at the potential active cluster, a possible role as a Zn 
protease has been suggested. However, a  Zn2+ ion did not localize to the 
pocket of p14a when crystals were grown in presence of Zn+2 (Szyperski, T. et 
al. 1998). It has also been suggested that the arrangement of the two 
histidines at the active center represents the active site of a ribonuclease, but 
biochemical assays to detect such activity could not confirm this (Szyperski, 
T. et al. 1998). Interestingly, the same cluster of amino acid residues is 
observed in GAPR-1, which is the object of study in this experimental work. 
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Figure 3. P14a tomato drawing based on NMR information. Left view. Representation of 
structural elements in p14a, containing four α-helices, and four β-strands. Ribbon structure of 
p14a obtained by Dr. Matthew Groves using MolScript® (Kraulis, P. 1991), Raster3D® 
(Bacon, D. Anderson, W. 1988). A similar structure has been described for Ves v5 from 
Vespula vulgaris (PDB 1QNX) and GAPR-1 isolated from GICs microdomains (see 
Discussion). Right view. Space-filling representation of P14a, showing the putative active site 
with histidinyl and glutamyl residues depicted in blue and red, respectively (Szyperski, T. et al. 
1998). 
 
2.1 Systemic acquired resistance (SAR) 
 
Secondary to the responses at the site of infection, long range responses are 
induced to protect distal parts of the plants. These responses are described 
as systemic resistance of plants against pathogens (Hammerschmidt, R. 
1999) or systemic acquired resistance (SAR). Many components associated 
with SAR, e.g. PR proteins, are expressed in response to a first infection, but 
the mechanisms of this response are not fully understood (Conrath, U. et al. 
2002).  For instance, salicylic acid (SA) in plants is a critical signaling 
molecule in the pathway(s) leading to local and systemic resistance  and SA 
is synthesized in response to infection both locally and systematically 
(Thomma, B. et al. 1998). Thus, the actual sites of de novo production of SA 
in non-infected plant might therefore contribute to induction of SAR (Meuwly, 
P. et al. 1995). NO has been implicated in the activation of plant defenses as 
well. The immune response of plants also depends on reactive oxygen 
intermediaries (ROI) and reactive nitrogen intermediaries (RNI) for signaling 
and apoptosis, and possibly for necrosis and direct antimicrobial actions 
(Klessig, D. F. et al. 2000).  
 
In mammalian cells, salicylates are potent scavengers of NO and its 
derivatives, and salicylates inhibit the activity and transcription of iNOS 
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(Farivar, R. S. Brecher, P. 1996). NO has previously been shown to serve as 
a key redox-active signal for the activation of various mammalian defense 
responses, including the inflammatory and innate immune responses 
(Schmidt, H. H. Walter, U. 1994;Mannick, J. B. et al. 1994; Stamler, J. S. 
1994). Infections, microbial products, and cytokines readily induce expression 
of NO synthase in tissue macrophages from rodents. Reactive nitrogen 
intermediaries (RNI) are critical in host defense not only because they can 
damage pathogens but also because they are immunoregulatory (Bogdan, C. 
et al. 2000). For instance, RNI can inhibit G proteins, activate or inhibit 
kinases, caspases, metalloproteases, transcription factors, and DNA 
methyltransferase, inhibit lymphocytes proliferation, alter cytokine and 
postaglanding production, and either cause or prevent apoptosis of the host 
cells (reviewed in Nathan, C. Shiloh, M. U. 2000).  
 
Resistant plants often develop a hypersensitive response (HR), in which 
necrotic lesions form at the site(s) of pathogen entry (reviewed in Klessig, D. 
F. et al. 2000). This localized cell death associated with the HR may help 
prevent the pathogen from spreading to uninfected tissues. Just before or 
concomitant with the appearance of a HR, an increased synthesis of several 
families of pathogenesis-related (PR) proteins is observed (Schneider, D. S. 
2002). It has been proposed that the HR response by activation of R 
(resistance) genes is responsible for controlling the entire intracellular 
environment such as guarding the secretory apparatus (Schneider, D. S. 
2002).  
 
The function of PR proteins in both SAR and HR is not known. By looking for 
similarities between the immune responses in plant and animal cells, likely the 
innate immune system in mammals is the one that resembles HR-producing 
infections in plants. The similarities are not only based on molecular 
mechanisms of action, but also on other levels such as monitoring endosomal 
traffic and activation of programmed cell death if traffic is disrupted. These 
considerations may be important for defining a role for PR proteins in general 
and for GAPR-1 specifically. GAPR-1 as potential regulator in the innate 
immune response may monitor the integrity of the Golgi apparatus due to its 
location at this organelle. 
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2.2 Mammalian PR-1 family members 
 
Since the identification plant PR-1 proteins, secretory proteins with a 
significant sequence homology have been identified in various other 
organisms including fruiting body proteins in fungi that are expressed during 
infection (Schuren, F. H. et al. 1993), insect allergens (Lu, G. et al. 1993; 
Schreiber, M. C. et al. 1997), mammalian CRISP proteins possibly involved in 
sperm maturation or sperm-egg fusion (Kratzschmar, J. et al. 1996), human 
GliPR/RTVP-1, specifically expressed in glial tumors (Murphy, E. V. et al. 
1995; Rich, T. et al. 1996), and in snake or lizard venoms, reported to block 
ryanodine receptors or cyclic nucleotide-gated ion channels (Morrissette, J. et 
al. 1995; Brown, R. L. et al. 1999). Together with plant PR-1 proteins, these 
proteins constitute a large PR-1 protein superfamily. Despite the diversity 
within this superfamily, very little is known about the function of the individual 
members and the plant PR proteins, described above, remain the most 
intensely studied family members. 
 
3 Purpose of this thesis 
 
During the characterization of lipid microdomains at the Golgi (GICs) 
(Gkantiragas, I. et al. 2001), a protein with an apparent molecular mass of 17 
kDa was identified. Cloning and preliminary biochemical characterization 
identified a novel protein, GAPR-1, belonging to the superfamily of PR 
proteins. Based on the primary amino acidic sequence of this protein, some 
potentially interesting characteristics were identified (Fig. 4). It contains i) a 
consensus sequence for myristoylation (grey box); ii) a putative caveolin-
binding domain (red box); iii) a coiled-coil structure (green box) and iv) an 
isolelectric point (pI) of 9.4, suggesting that GAPR-1 is a highly hydrophilic 
protein. Further characterization of GAPR-1 showed that the protein is 
differentially expressed  in various tissues (Eberle, H. B. et al. 2002). For 
instance, GAPR-1 is highly expressed in immunocompetent organs and cells 
such as in lungs, spleen, and lymphocytes, but is absent in e.g. liver, heart, 
and brain. Here, this basic information was used to study the interaction of 
GAPR-1 with membranes (Section 1), to obtain structural information on the 
protein (in collaboration with Prof. Dr. Irmgard Sinning at the EMBL/BZH- 
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Heidelberg) (Section 2), and to identify proteins that interact with GAPR-1 
(Section 2.4). 
 
 
 
 
 
Figure 4. cDNA-derived sequence of GAPR-1. The consensus sequence for N-
myristoylation is indicated by the grey box. The potential protein-protein interacting sites, i.e. a 
coiled-coil region and a caveolin-interacting region are indicated in green and red, 
respectively. 
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Results  
1 Membrane association of GAPR-1 
1.1 N-myristoylation of GAPR-1 in Escherichia coli 
The enzymology of the myristoylation reaction is well understood. Proteins that 
are destined to become myristoylated contain the N-terminal sequence: Met-Gly-
X-X-X-Ser/Thr (for a review see Resh, M. 1999). The initiating methionine is 
removed co-translationally by methionine amino-peptidase, and myristate is 
linked to Gly-2 via an amide bond by an N-myristoyl transferase. To investigate 
whether the consensus sequence for N-myristoylation  in GAPR-1 (Fig. 4) is a 
substrate of myristoyl-CoA:protein N-myristoyl-transferase (NMT1), an E .coli 
strain was used that contained two plasmids for simultaneous expression of 
GAPR-1 (expression vector pQE60, Eberle, H. B. et al. 2002) and  yeast NMT1 
(in expression vector pBB131 Duronio, R. J. et al. 1990) (Fig. 5 panel A). The 
vectors were designed so that they could be simultaneously maintained as stable 
episomal plasmids and that independent induction of transcription of their 
heterologous DNA sequences was possible. The expression of NMT was placed 
under the control of the isopropyl-β-D-thiogalactopyranoside (IPTG)-inducible tac 
promoter, and GAPR-1 under the control of the T5 promoter. The various 
plasmid combinations were compared for the efficiency of GAPR-1 myristoylation 
during expression of proteins upon induction with IPTG. To determine 
myristoylation efficiency of GAPR-1, [3H]-myristic acid was added during the 
overexpression. Subsequently, lysates were prepared from the E. coli cultures, 
and subjected to SDS-PAGE (Fig. 5, middle panel B). Autoradiography showed 
that in the presence of NMT1 and GAPR-1, a labeled band of 17 kDa was 
observed and indicated that the radiolabel is readily incorporated into GAPR-1 
(Fig. 5, lane 1, bottom panel C). Labeling of GAPR-1 was absolutely dependent 
on the presence of NMT1. E. coli that expressed NMT1 but lacked GAPR-1, or E. 
coli that lacked NMT1 but expressed GAPR-1, failed to label the 17 KDa protein 
with the tritiated fatty acid (Fig. 5, panel B and C, lanes 5 and 3, respectively). 
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Figure 5. [3H]-Myristate-labeled GAPR-1 in E. coli. (A) Schematic presentation of plasmid 
constructs used to express NMT1 and GAPR-1 in E. coli. KANR, gene for kanamycin resistance; 
AMPR, gene for ampicilin resistance. (B) The radiolabeling conditions were compared for induced 
(IPTG) and non-induced bacteria, containing distinct plasmid combinations: transformed bacteria 
with GAPR-1 and NMT1 (lanes 1 and 2) were induced (lane 1) or not induced (lane 2) with IPTG 
(1mM) in the presence of [3H] myristic acid (50µCi/ml culture). Cells were lysed in SDS-gel loading 
buffer 1, heated for 5 min at 95o C, and after centrifugation (5 min, 14000 rpm), an aliquot of the 
supernatant (lysate) (20µl) was mixed with (5µl) SDS-gel loading buffer 2 (5X), and analyzed by 
SDS-PAGE (14% acrylamide). After staining with Coomassie Blue, the dried gel was exposed to a 
film. Lysates from bacteria containing only pQE60 (GAPR-1) (lanes 3 and 4) or pBB131 (NMT1) 
(lanes 5 and 6) were induced or not induced with IPTG (as indicated in figure) and analyzed as 
described above. 
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1.2 N-myristoylation of GAPR-1 in vivo 
To determine whether the consensus sequence for N-myristoylation also results in 
myristoylation of GAPR-1 in vivo, proteins from a large-scale preparation of Golgi-
derived detergent-insoluble complexes (GICs) were separated by SDS-PAGE. 
After staining the gel with Coomassie Blue, the protein band at 17 kDa was excised 
from the gel and digested with trypsin. The resulting peptides were analyzed by 
electrospray ionization mass spectrometry (ESI-MS) (Fig. 6). Trypsinization of the 
GAPR-1 band generated 21 major peptides (Fig. 6A, upper panel). If native GAPR-
1 is myristoylated, then a myristoylated dipeptide [myrGK] with a theoretical 
[M+H]+ signal at m/z 414.33 is expected to be present. The survey spectrum of the 
tryptic digest of GAPR-1 showed a signal at m/z 414.327 (Fig. 6A, lower panel), 
consistent with the calculated m/z value for the myristoylated fragment. Also the 
isotopic 13C-peak at m/z 415.33 could be detected. The ion at m/z 414.327 was 
further analyzed by ESI tandem mass spectrometry, and the products obtained 
from this ion by fragmentation are displayed in Fig. 6B. All major fragment ions in 
this spectrum can be assigned to the myrGK sequence, as indicated in Fig. 6B 
(insert) and Table 1.  In particular the fragment ion triplet at 211, 240 and 268 is 
indicative of the myrG structure. In summary, mass spectroscopic data show that 
native GAPR-1 is myristoylated at the N-terminus. All the ESI-MS data were 
obtained and analyzed in collaboration with Dr. Andreas Schlosser and Dr. Wolf 
Lehmann at the Cancer Center Heidelberg (DKFZ). 
 
Table 1. Summary of positive nanoESI product ion spectrum of expected and calculated MS/MS 
signals for myrGK fragment of GAPR-1.  
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 Figure 6. In vivo myristoylation of GAPR-1. (A) Positive nanoESI spectrum of peptides derived 
from an in-gel digest of native GAPR-1. The top panel shows the complete survey spectrum, and 
the lower panel the expanded view from m/z 413 to 417, showing the singly protonated molecular 
ion of the T1 fragment including the 13C isotope peak. (B) Positive nanoESI product ion spectrum of 
m/z 414.33. The spectrum shows the key fragments for the myrG structure at m/z 211, 240 and 268 
and sequence–specific fragment ions, which identify the peptide as T1 fragment myrGK of GAPR-1. 
Data obtained and analyzed by Dr. Andreas Schlösser and Dr. Wolf Lehmann (DKFZ-Heidelberg). 
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1.3 Association of GAPR-1 with Golgi membranes 
 Myristoylation is necessary but not sufficient for membrane binding of 
myristoylated proteins (Peitzsch, R. M. McLaughlin, S. 1993). A second signal for 
stable membrane binding of N-myristoylated proteins has been defined as either a 
polybasic cluster of amino acids or a palmitate moiety (Resh, M. D. 1999). GAPR-1 
is tightly associated with Golgi membranes, which is reflected by the absence of 
GAPR-1 from the cytosolic fraction: GAPR-1 could not be detected by 
immunoprecipitation from large amounts of cytosol (Fig. 7A). When the Golgi 
structure is disrupted with Brefeldin A and GAPR-1 is dispersed in the cell (Eberle, 
H. B. et al. 2002), GAPR-1 remains associated with the membrane fraction of 
these cells as determined by efficient immunoprecipitation the total membrane 
fraction. This indicates that GAPR-1 is absent from the cytosol (see, however 
section 1.6). The characteristics of this tight membrane association of GAPR-1 
were further investigated by incubation of isolated Golgi membranes under various 
conditions. As shown in Fig. 7B, treatment of Golgi membranes with 1 M KCl did 
not strip GAPR-1 off the membranes, whereas NSF, a peripheral Golgi membrane 
protein (Block, M. R. et al. 1988) is affected by this treatment. Alkaline treatment of 
the membranes, which causes the dissociation of most peripheral membrane 
proteins, did affect the membrane binding of NSF and GAPR-1 (Fig. 7B). As a 
control, p23, a type I transmembrane protein of the Golgi complex (Sohn, K. et al. 
1996), remains present in salt or alkaline-treated membranes (Fig. 7B). Biophysical 
studies have established that the binding energy provided by myristate is relatively 
low (with a Kd of 10-4 M ) (Peitzsch, R. M. McLaughlin, S. 1993) and not sufficient to 
stably anchor a protein to a lipid membrane (Moffet, S. B. et al. 2000). To 
determine whether the myristoyl moiety of GAPR-1 contributes to the salt-resistant 
membrane binding, purified non-myristoylated GAPR-1 was bound to isolated 
Golgi membranes (Fig. 7C). Upon salt treatment of the membranes, most of the 
non-myristoylated GAPR-1 is stripped again from the membranes. These data 
indicate that native GAPR-1 is bound to Golgi membranes not only by ionic 
interactions, but also through the myristoyl moiety, which affects membrane 
anchoring of the protein. The primary structure of GAPR-1 shows the presence of 
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basic residues in the N-terminal region. An amino-acidic stretch at the N-terminus 
(21 amino acids) has a theoretical pI 9.8, containing five positively charged amino 
acids [Arg-Lys]. The 151LPKK154 sequence at the C-terminus represents another 
potential positive structure that may play a role on membrane interaction. The high 
overall pI of GAPR-1 suggests that a contribution of several positively charged 
regions together with the myristoyl moiety allows the protein to bind strongly to the 
membrane.  
1.4 GAPR-1 interaction with Caveolin-1 
A number of studies support the hypothesis that caveolin provides a direct mean 
for proteins to be sequestered within lipid-enriched microdomains (Oh, P. 
Schnitzer, J. E. 2001). Many proteins that interact with caveolin, including G-
protein α subunits, Ha-Ras, Src family tyrosine kinases, endothelial NOS, 1 EGF-R 
and related receptor tyrosine kinases, and protein kinase C isoforms (Okamoto, T. 
et al. 1998) do so via an interaction with a common putative caveolin-binding motif 
(Fig. 4, ΦXΦXXXXΦ, where Φ is aromatic amino acid Trp, Phe, or Tyr). GAPR-1 
also contains this putative caveolin-binding motif (YnFqqpgF), which might 
contribute to its strong membrane-binding. To determine a direct interaction 
between caveolin-1 and GAPR-1, co-immunoprecipitation studies were carried out. 
Under native conditions using various detergents caveolin could not be co-
immunoprecipitated with GAPR-1 or vice versa (data not shown). For that reason, 
co-immunoprecipitation studies were performed after chemical crosslinking of 
proteins in Golgi membranes. As shown in Fig. 7D, crosslinking with N-
Hydroxylsulfosuccinimidyl-4-azidobenzoate resulted in an irradiation-dependent 
crosslink product of caveolin-1 at 40-45kDa (Fig. 7D left panel). 
When GAPR-1 was immunoprecipitated from similar incubations (10 fold upscale 
of incubations), caveolin-1 was found to co-immunoprecipitate with GAPR-1 in a 
crosslink product of 40-45kDa (Fig. 7D, lane 3). Co-immunoprecipitation of 
crosslinked Golgi membranes with Caveolin-1 antibody produced a similar result. 
GAPR-1 was co-immunoprecipitated in a crosslinked product that runs at 40-
45kDa (Fig. 7D, lane 6), corresponding to a similar product observed for co-
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immunoprecipitation with GAPR-1. These results indicate a direct interaction of 
GAPR-1 with caveolin-1. The crosslink products at high molecular weights (HMW) 
(Fig. 7D, lane 6) appeared only when immunoprecipitations were performed with 
caveolin-1 antibodies and western-blotting was performed with a GAPR-1 antibody. 
This indicates that GAPR-1 can interact with caveolin-oligomers. 
 
 
 
 
Figure 7.  Interaction of GAPR-1 with 
Golgi membranes. The incubations were 
analyzed by SDS-PAGE and western 
blotting for the presence of the indicated 
proteins. (A) CHO cells were incubated for 
30 minutes in the absence (lane 2 and 3) or 
presence of 5 µM Brefeldin A (lane 4 and 5). 
After homogenization, the homogenate was 
centrifuged for 1 hour at 100,000 g to yield a 
total membrane (lanes 2 and 4) and a 
cytosolic fraction (lanes 3 and 5). GAPR-1 
was immunoprecipitated from the membrane 
fraction (2mg) or from the cytosolic fraction 
(2mg). As a control, GAPR-1 was 
immunoprecipitated from isolated CHO 
Golgi membranes (50µg) (lane 1). (B) 50µg 
of CHO Golgi membranes (lanes1-3) were 
incubated for 30 minutes on ice in the 
absence (lane 1) or presence of 1 M KCl 
(lane 2) or with 0.1 M Na2CO3, pH 11 (lane 
3). After centrifugation through a 15% (w/v) 
sucrose cushion, equal amounts of 
membranes (29 nmol phospholipid) were 
analyzed. (C) CHO Golgi membranes (25 
µg) were incubated for 30 minutes at 4oC in 
the absence (lane 1) or presence (lanes 2 
and 3) of 3µl of bacterial expressed and 
purified, non-myristoylated GAPR-1 (5.3 
mg/ml) in 25 mM Hepes/KOH, pH 7.2, 20 
mM KCl, 2.5 mM magnesium acetate, 0.1 M 
sucrose, 1 mg/ml ovalbumine and 10 mM 
DTT. Subsequently, KCl (1 M final 
concentration) was added to one incubation 
(lane 3) and incubated further for 30 min at 
4oC. Golgi membranes were re-isolated by 
centrifugation through a 15% (w/v) sucrose 
cushion. (D) CHO Golgi membranes (50µg) 
were incubated with N-
Hydroxylsulfosuccinimidyl-4-azidobenzoate 
(5mM) in PBS for 30 minutes at RT and left 
on ice (lane1, and 4) or irradiated for 10 
minutes at 254 nm (lane 2 and 5) and 
analyzed for crosslinked products. For 
immunoprecipitation (lane 3, and 6), 500 µg 
of Golgi membranes each were used for 
immunoprecipitation of GAPR-1 or Caveolin-
1. After western blotting, the PVDF 
membrane (left, immunoprecipitation using 
α-GAPR-1) was incubated first with α-
Caveolin-1, followed by α-GAPR-1, or the 
PVDF membrane (right, immunoprecipitation 
using α-Caveolin-1) was incubated first with 
α-GAPR-1, followed by α-Caveolin-1
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1.5 Phosphorylation of GAPR-1 in vivo.  
The partitioning of myristoylated proteins to cellular membranes can be sensitive to 
additional factors that affect the binding of these proteins to membranes. These 
factors can control the reversible translocation of myristoylated proteins onto 
membranes. The primary structure of GAPR-1 shows several predicted 
phosphorylation sites (NETPHOS 2.0 http://www.cbs.dtu.dk/services/NetPhos/) 
(Table 2). This program calculates a score based on the confidence of the 
prediction and similarity to known phosphorylation sites. To investigate whether 
GAPR-1 can be phosphorylated in vivo, CHO cells were incubated 4 hrs with 
radiolabeled inorganic phosphate (32Pi). Cells were lysed, and cytosol and total 
membranes were isolated by centrifugation. The membrane fraction was 
solubilized in 1% SDS, quenched to 0.1% SDS with PEN buffer containing 1% 
Triton X-100, and subjected to immunoprecipitation with an antibody against 
GAPR-1 (α-1852). Fig. 8 (lane 2) shows that the immunoprecipitated protein 
GAPR-1 (western blot) is radioactively labeled due to incorporation of 32P in the 
protein.  These data indicate that GAPR-1 is phosphorylated in vivo. The extent of 
GAPR-1 phosphorylation seems not to be affected by treatment with phosphatase 
inhibitors (lane 2 and 3).  
 
 
Figure 8. In vivo phosphorylation of 
GAPR-1. Confluent CHO wt cells were 
incubated for 4 hrs in DMEM medium 
(phosphate and serum free) at 37oC in the 
absence (lane 1) or presence (lanes 2 and 
3) of [32P] 0.25mCi/ml. Cells were incubated 
in the absence (lanes 1 and 2) or the 
presence (lane 3) of phosphatase inhibitors. 
Phophatase inhibitors were added during 
homogenization and IP. Cells were washed, 
harvested and lysed. The homogenate was 
centrifuged 1hr at 100,000 xg to isolate a 
total membrane fraction (pellet). The total 
membrane fraction was dissolved in 1% 
SDS and incubated 5 min at 95oC. After 
incubation, the fraction was quenched to 
0.1% SDS by 10-fold dilution in PEN buffer 
containing 1% Triton X-100. GAPR-1 was 
immunoprecipitated using α-GAPR-1 (α-
1852) antibody. Immunoprecipitated proteins 
were separated by SDS-PAGE and 
analyzed by western-blotting (upper panel) 
and autoradiography by exposure of the 
western blot to X-ray film (lower panel).  
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Table 2. Predicted phosphorylation sites present on GAPR-1. The program NETPHOS (2.0) 
was used to predict phosphorylation of amino acids in GAPR-1. Phosphorylation sites are sorted by 
their score. *Score indicates the likeliness of phosphorylation. Threshold score: 0.500.  
 
 
1.6 Effect of phosphorylation on the partitioning of GAPR-1 to lipid-
enriched microdomains. 
 
Triton X-100 treatment of Golgi membranes or plasma membranes in the cold 
allows isolation of a detergent-insoluble fraction. The partitioning of proteins to the 
detergent-resistant fraction can depend on post-translational modifications (Moffet, 
S. B. et al.  2000). Phosphorylation therefore may have an effect on the partitioning 
of GAPR-1 into Golgi-derived microdomain complexes (GICs) as well.  To analyze 
this possibility, total cell membranes, obtained from 32P-treated CHO cells, were 
resuspended in cold PEN buffer containing 1% Triton X-100 and detergent-soluble 
and insoluble fractions were analyzed for the presence of phosphorylated GAPR-1. 
A major pool of GAPR-1 is insoluble in Triton X-100 (Fig. 9A, lane 1, upper panel), 
and this fraction is highly phosphorylated (Fig. 9A, lane 1, bottom panel); a minor 
pool of GAPR-1 is soluble in Triton X-100 (Fig. 9A, lane2, upper panel). This 
soluble fraction shows a low level of phosphorylation (Fig. 9A, lane 2, bottom 
panel). Interestingly, CHO cytosol of treated cells shows a barely detectable 
fraction of GARP-1 by western blot analysis (Fig. 9A, lane 3, upper panel), but a 
relatively high level of phosphorylation (radioactivity/amount of protein) is observed 
in this sample (Fig. 9, lane 3, bottom panel). The radioactive signals were 
Results 
 28
quantified using the program Quantity One® (BioRad™). Fig. 9B shows that 
approximately 32.5% (calculated as percentage of total radioactive signal) of the 
incorporated Phosphate in GAPR-1 has a cytosolic localization. The soluble 
fraction in Triton X-100 represents approximately 11.6%. These data suggest that 
GAPR-1 can be phosphorylated in vivo and that phosphorylation of GAPR-1 can 
play a role on the dynamics of GAPR-1 association with Golgi membranes.  
  
 
 
 
 
 
Figure 9.  Phosphorylation of GAPR-1 and partitioning into lipid rafts. A) Confluent CHO wt 
cells were incubated for 4 hrs in DMEM medium (phosphate and serum free) at 37oC in the 
presence of [32P] 0,25mCi/ml.  Cells were washed, harvested and lysed. The homogenate was 
centrifuged 1hr at 100,000 xg to isolate a total membrane fraction (pellet) and a cytosol fraction 
(supernatant). The total membrane fraction was dissolved in 1% TX-100/PEN buffer and incubated 
for 30 min in the cold. After incubation, the fraction was centrifuged 1 hr at 100,000 xg to yield 
soluble (lane 2) and insoluble (lane 1) fractions. GAPR-1 was immunoprecipitated from both 
fractions as well as from cytosol of lysated cells (lane 3). Proteins in the immunoprecipitates were 
separated by SDS-PAGE and analyzed for the presence of GAPR-1 by western-blotting (upper 
panel) and for phosphorylation of GAPR-1 by autoradiography (lower panel). B) Quantification of 
the radioactive signals by Quantity One® (Biorad). 
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2 Structural Characteristics of GAPR-1 
2.1 Large Scale Purification of GAPR-1  
 
Structure determination of proteins is important in several ways. The function of a 
protein is linked to its three dimensional structure, and highly resolved structures 
can lead to a clear understanding of the possible function of a protein. Structures 
can also discriminate between evolutionary changes in the primary structure of 
related or non-related species. To obtain a crystal structure of GAPR-1, it was 
necessary to obtain protein crystals of suitable size and diffraction quality for X-
ray analysis. GAPR-1 has several biochemical characteristics that can be used to 
obtain a highly purified protein fraction: an isoelectric point (pI) of 9.4, and a 
molecular weight of 17,2 KDa, useful in ion exchange and gel filtration 
chromatography, respectively. 
The cDNA encoding GAPR-1 was cloned in the vector pQE60, and after 
transformation, GAPR-1 was overexpressed in M15/REP4 bacteria. 
Recombinant wtGAPR-1 was purified from overexpression in 12 liters of LB-
medium (Fig. 10). Diluted lysates were applied on to a DEAE-sepharose (anion 
exchange support) to remove most of the bacterial proteins in the lysate, followed 
by a High S-support column (cation exchange). GAPR-1 has a high pI (9.4), and 
the overexpressed protein was bound to the High S-support (Fig. 10A, lane 5). 
After washing, proteins were eluted from the cation exchange column by a salt 
gradient. The chromatogram and corresponding gels (Fig. 10B (Ieft part), panel A 
and B) indicate that GAPR-1 eluted at a salt concentration of 250-300mM, 
corresponding to fractions 18 to 22. These fractions were pooled and loaded onto 
a Superdex 200 gel filtration column. Separation of proteins by gel filtration 
produced several fractions (46-53) (Fig. 10B (right part), panel B) with GAPR-1, 
purified to apparent homogeneity. These fractions were used for further studies, 
including the generation of GAPR-1 crystals by Dr. Matthew Groves.   
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Figure 10A. Overexpression of GAPR-1 in bacteria (M15/REP4). Figure shows distinct steps 
during induction of GAPR-1 expression. Cells collected prior to induction (lane 1) by 1mM IPTG, 
and after 3 hrs of induction (lane 2). Cells were collected and lysed by French press. The 
homogenate (lane 3) was cleared after 100000 xg centrifugation, and diluted 1:6 with buffer Tris-
HCl 50mM; pH 7.5; 50mM. 1.2 L of Lysate was loaded onto a DEAE column  at a flow rate of 0.5 
ml/min and the flow through (lane 4) was applied to a cation exchange column (High S-support), 
and washed Tris-HCl 50mM pH7.5; 50mM NaCl (lane 5, flow through). Proteins were eluted from 
the column with a NaCl gradient (50mM to 1000mM). 
 
 
 
 
 
 
 
Figure 10B. Large scale purification of GAPR-1. Left panel: Cation exchange chromatography 
(High S-support cation exchange column). Panel A shows the chromatogram profile (amount of 
protein and conductivity versus fractions) obtained during elution of proteins from the High S 
column by a sodium chloride (NaCl) gradient (in 50 mM to 1M in Tris 50 mM, pH 7.5). Proteins 
eluted between 250 to 300mM NaCl were analyzed by SDS-PAGE (14%), and coomassie blue 
staining. Right panel: Gel filtration (Superdex 200). Upper panel (C) shows the chromatogram profile 
(µg protein vs fractions) of eluting proteins (Tris 50 mM, pH 7.5, 50 mM NaCl), and the bottom panel 
(D) shows the analysis of selected fractions by SDS-PAGE (14%) and coomassie blue staining. 
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2.2 Crystal structure of GAPR-1 
Two conditions from the initial screen produced micro crystals from which further 
screens were designed. Lens-shape crystals large enough for X-ray analysis were 
obtained in 20% (v/v) PEG 8K, 100mM Bis-Tris-HCl pH 7.0, 200mM magnesium 
acetate. These crystals appeared after 3-4 days and were suitable for analysis 
after 6-7 days (0.4 x 0.2 x 0.2mm). Diffraction from these crystals was measured 
in-house to 3.0Å. Hexagonal crystals were obtained in 30% PEG 4K, 100mM Tris-
HCl ph 8.0, 140mM magnesium chloride. These crystals appeared after 7-8 days 
and were suitable for analysis after 10-12 days (0.4 x 0.4 x 0.4mm). The hexagonal 
crystals had similar cell parameters to the lens-shaped crystals and shared the 
same point group, but diffracted in-house to 2.1Å. A complete data set to 1.5Å was 
collected on a MarCCD detector at beamline ID14 EH-2 at the ESRF (Table 3). A 
low resolution pass was made using a crystal-to-detector distance of 200mm and 
an oscillation range of 100o in 1o steps. A high resolution pass was made at a 
crystal-to-detector distance of 110mm and an oscillation range of 130o in 0.5o 
steps. Auto-indexing yielded unit-cell parameters of a=b=73.5, c=63.2Å, 
α=β=90oγ=120o in the trigonal point group P32l. The 00l axial reflections are 
markedly stronger for l=3n (n integer) indicating that the space group is either 
P3121 or P3221. Data completeness and I/σ(I) were 97.2% and 3.6, respectively, 
overall and 90.4% and 2.8, respectively, for the 1.56-1.49Å highest resolution shell. 
Using a molecular weight of 17kDa for the monomer, the predicted Matthews 
coefficient (VM) for a single molecule in the asymmetric unit is 2.81, within the usual 
range for a protein crystal, whereas the Matthews coefficient for two molecules in 
the asymmetric unit is 1.3. Similarly, the predicted solvent content for a single 
molecule in the asymmetric unit is 56% and for two molecules the predicted solvent 
content is 11%. Crystal structure solved by single isomorphous  replacement (SIR). 
All crystal structure data were obtained and analyzed by Dr. Matthew Groves at the 
European Molecular Biology Laboratory (EMBL)/ Biochemistry Center Heidelberg 
(BZH). 
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Table 3. X-Ray diffraction data. 
 
 
Our data indicate that GAPR-1 is a Golgi localized peripheral membrane protein, 
with a cytosolic orientation (Eberle, H. B. et al. 2002). To investigate further the 
implications for its orientation, a working model was proposed for the topological 
positioning of GAPR-1 at the Golgi membrane.  GAPR-1 has a positive cluster at 
the N-terminus (Fig. 11), and C-terminus, both of which are proposed to interact to 
the membrane cytosolic leaflet. The interaction proposed is via positive residues 
(Lys-Arg), and a myristic acid. Fig. 11 depicts these positive elements, and 
suggests a geometric representation of the interaction. However, it is possible to 
separate GAPR-1 in several structural features or regions, and representing each 
one of them in the model. Region I can be assigned from amino acid 2 (Gly) to 21, 
which includes the N-myristoylation and five positive residues. Region II assigned 
to the amino acids 25 to 55, representing a “hepta repeat”. This structure has been 
suggested as protein-protein interacting motif.  Region III assigned to the putative 
caveolin-binding motif and the C-terminus. The folding of the “caveolin binding 
motif” in region III seems to result in a highly strained conformation for each amino 
acid residue in the structure that is exposed on the surface (Fig. 11). The cleft 
region is formed between region II and III. A Similar conformation has shown to be 
present in p14a, and suggested to be a conserved active site (Szyperski, T. et al. 
1998). The shape of the cleft is like a left-hand hollow in which region I form the 
palm, region II the fingers and domain III casts the thumb. The cleft runs across the 
protein, and opens up towards the cytosol and has a α-β-α sandwich core 
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structure- (Fig. 11).  Four amino acids that locate to the cleft (His 54, Glu65, Glu86 
and His 103) are conserved throughout the family members of plant-pathogenesis-
related proteins (group1) and could represent an active site. 
 
 
 
 
Figure 11.  Representation of GAPR-1 attachment to the membrane. Overall structure of 
GAPR-1 showing distinct regions. Region I, positive stretch of amino acids within the C- and N-
terminus, and myristate. Region II, assigned to the coiled-coil structure. Region III, represents the 
Caveolin-binding motif. Between Region II and III runs a cleft through the protein, and possibly 
represents an active center in GAPR-1. Ribbon representation of GAPR-1 obtained by Dr. Matthew 
Goves using Raster3D® (Bacon, D. Anderson, W. 1988); and MolScript® (Kraulis, P. 1991) 
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2.3 Role of conserved amino-acids in GAPR-1 
To evaluate the possibility that the potential active site (His54, Glu65, Glu86, and 
His103) has any implication in the function of GAPR-1, a mutant of GAPR-1 was 
produced in which His54, His103, Glu65, and Glu86 were replaced with alanines 
(Fig. 12).  
 
 
 
Figure 12. Site-directed mutagenesis of GAPR-1. Primary sequence of GAPR-1 wild type 
showing the amino acid changed during site-directed mutagenesis. His54, Glu65, Glu86 and 
His103 were replaced by alanine in the same position to yield a mutant protein (GAPR-1 mut), 
bearing Ala54, Ala65, Ala86 and Ala103. The changes in GAPR-1 wild type were confirmed by DNA 
sequencing. Site-directed mutagenesis was performed as described by QIAGEN site-directed 
mutagenesis kit. 
 
The protein lacking the “conserved cluster” (GAPR-1mut) was overexpressed and 
purified using similar procedures as described for the wt protein (see above). To 
determine possible interacting partners of GAPR-1, both GAPR-1wt and GAPR-
1mut (as a negative control) were covalently linked to CNBr-Sepharose 4B for 
affinity chromatography. To analyze whether this mutation has an impact on the 
possible interaction of GAPR-1 to unknown cytosolic components, the affinity 
columns both GAPR-1wt and GAPR-1mut were loaded with equal amounts of CHO 
cytosol. After washing the columns, bound proteins were eluted from the column by 
use of a salt gradient. Fig. 13 shows the chromatographic profiles and 
corresponding analyses by SDS-PAGE of fractions collected during the elution. 
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SDS-PAGE analysis of proteins interacting with GAPR-1wt shows a complex 
protein mixture binding to the column, which eluted at 330 mM NaCl approximately 
(Fig. 13A, upper panel, peak at fraction 14). For GAPR-1mut, a somewhat broader 
peak eluted from the column (Fig. 13B, upper panel, peak ranging from 200 mM to 
740 mM NaCl), and the amount of protein was approximately two fold less as 
compared to the GAPR-1wt chromatographic profile at 280nm. The protein profiles 
eluted from GAPR-1wt and GAPR-1mut column show a similar protein pattern, 
indicating that the same proteins bind, with different degrees of affinity (Fig. 13A 
and B, bottom panels). 
 
 
 
Figure 13. Affinity chromatography of CHO cytosolic proteins to Sepharose-bound GAPR-1.  
(A) 5 mg of GAPR-1 wt were bound to 1ml of swelled-gel CnBr-Sepharose 4B fast flow. CHO 
cytosol was prepared according to the protocol described in Materials and Methods. 200 ml of 
cytosol (1mg/ml) was applied onto the GAPR-1 wt column at a flow rate of 0,5ml/min, washed with 
100 volumes of buffer Tris-HCl 50mM, NaCl 50mM, pH7.4, until an optical density of 0,01 (or lower) 
at 280 nm was reached. After washing, a NaCl gradient (50mM to 1M) in buffer (50mM Tris-HCl, 
pH7.4) was applied at a flow rate of 50µl//min, and fractions were collected. Fractions 11 to 24, 
corresponding to the peak fractions observed on the protein profile were analyzed by SDS-PAGE 
and coomassie blue staining. (B) 5 mg of GAPR-1 mut were bound to 1ml to CnBr-Sepharose 4B 
fast flow. Determination of proteins from cytosol that interact with GAPR-1mut was exactly as 
described for GAPR-1wt. Note: The coupling efficiency was determined by BCA protein 
quantification and indicated that the coupling efficiency was similar for both GAPR-1wt and for 
GAPR-1mut (98% coupling efficiency of protein binding to beads).  
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2.4 Identification of proteins that bind to the GAPR-1 affinity column 
2.4.1 Identification of proteins in CHO cytosol that bind GAPR-1 
 
 To pursue the identification of the interacting partners of GAPR-1, a mass 
spectrometric (MALDI-TOF) analysis was performed on the major protein bands, 
eluting from the GAPR-1wt affinity column (Fig. 14). Eluted proteins were resolved 
on two different types of gels:  a 4-12% SDS-PAGE gel for identification of proteins 
above 31kDa (Fig. 14, panel A), and a 12% SDS-PAGE for proteins below 31kDa 
(Fig. 14, panel B). By peptide mass fingerprinting, 17 proteins  were identified in 20 
selected bands (Table 4). When these proteins were analyzed for functional motifs, 
the most interesting common feature was the presence of an RNA binding motif in 
9 of the 17 proteins identified (Burd, C. G., Dreyfuss, G 1994). The identified RNA-
binding proteins fall into three major functional groups: 1) t-RNA synthetases such 
as Tyrosyl and Threonyl -tRNA synthetases and bifunctional aminoacyl-tRNA 
synthetase (Weiner, A. M. Maizels, N. 1999) (Wakasugi, K. Schimmel, P. 1999); 2) 
proteins involved in RNA modificiation or stabilization, such as hnRNPs; and 3) 
regulators of cell cycle and apoptosis such as Nucleolin, NS1-associated protein 1  
(Hresko, R. C. Mueckler, M. 2002; Mizutani, A. et al. 2000). Mass spec analysis (by 
fingerprinting) of the bound CHO proteins was limited due to the fact that not the 
entire genome of this species is known.  Most of the proteins identified are not 
exact matches but have homologs in Homo sapiens. Only for two bands a 
Cricetulus griseus protein was found: Nucleolin (Bugler, B. et al. 1982), and 
thioredoxin peroxidase (Hofmann, B. et al. 2002).    
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Figure 14. Identification of CHO cytosolic proteins binding to GAPR-1wt. Panel A shows 
peptide mass fingerprinting of major protein bands above 31kDa, separated by SDS PAGE (4-12%) 
and stained by coomassie blue. Panel B shows peptide mass fingerprinting of major protein bands 
below 31kDa, separated by SDS-PAGE (12%) and stained by coomassie blue. 
 
 
2.4.2 Identification of proteins present in complex pull down by GAPR-1 
affinity column in HeLa cells  
 
Due to the lack of a comprehensive database for Chinese Hamster (Cricetulus 
griseus), the experiments were repeated with cytosol from HeLa cells (Homo 
sapiens derived) cytosol as a source for the identification of interacting partners. In 
fact, GAPR-1, employed in these experiments, was cloned from a human fetal 
brain library (Eberle, H. B. et al. 2002). Fig. 15 shows the components in HeLa cell 
cytosol that bound to the GAPR-1wt column and which were identified by MALDI-
TOF. Of the 42 proteins identified, 7 are ribosomal proteins: 3 are part of the large 
ribosomal subunit, and 4 are part of the small ribosomal subunit. Among the non- 
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Table 4. CHO proteins identified to bind GAPR-1wt. Protein identification was performed by a 
combination of in-gel digestion, MALDI-TOF and database searching 
(http://129.206.154.159/mascot/). 
 
 
A summary of proteins identified after separation by 4-12% and 12% SDS-PAGE. a. Represents the 
theoretical molecular weight. MS analysis of all proteins listed were found to be in good agreement 
with the theoretical molecular weight. b. Isoelectric point (pI) determined by ProParamTool 
(http://www.expasy.org/tools/protparam.html), a web based software for computation of various 
physical and chemical properties of a given protein.  
 
ribosomal proteins identified are: Alternative Splicing Factor 1, 2 and 3; Casein 
kinase 2, aminoacyl-tRNA synthetases (Asparagine, Histidine, Isoleucine, 
Tyrosine), Template activating factor 1 (α,β), DNA helicase 2, and RNA helicase A 
(Table 5). GAPR-1 bound  proteins from Hela cell cytosol can be grouped by 
functional features as well: several proteins are involved in: 1) ribosome biogenesis 
(Ginisty, H. et al. 1999), RNA binding, and processing; and 2) cell cycle, 
proliferation and apoptosis (Burd, C. G., Dreyfuss, G 1994; Yanagida, M. et al. 
2001) Zhu, D. et al. 2002; (Wakasugi, K. Schimmel, P. 1999). This classification 
overlaps significantly with that for proteins from CHO cytosol and several of these 
cytosolic HeLa cell proteins interacting to GAPR-1 have been identified in CHO 
cytosol as well such as bifunctional aminoacyl-tRNA synthetase, 60S ribosomal 
protein L22, U2 sn- RNP protein A, ribosomal protein L5, and nucleolin (table 4 and 
5). 
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Figure 15. Identification of Hela cell cytosolic proteins binding to GAPR-1wt. Panel A shows 
peptide mass fingerprinting of major protein bands above 31kDa, separated by SDS PAGE (4-
12%) and stained by coomassie blue. Panel B shows peptide mass fingerprinting of major protein 
bands below 31kDa, separated by SDS-PAGE (12%) and stained by coomassie blue. 
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Table 5. Hela cell proteins identified to bind GAPR-1wt. Protein identification was performed by a 
combination of in-gel digestion, MALDI-TOF and database searching 
(http://129.206.154.159/mascot/). 
 
 
 
 
 
A summary of proteins identified after separated by 4-12% and 12% SDS-PAGE. a Represents 
the theoretical molecular weight. MS analysis of all proteins listed were found to be in good 
agreement with the theoretical molecular weight. b Isoelectric point (pI) determined by 
ProParamTool (http://www.expasy.org/tools/protparam.html), a web based software for 
computation of various physical and chemical properties of a given protein.  
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2.4.3 Identification of a potential GAPR- High Molecular Weight complex 
that binds GAPR-1 
 
It seemed unlikely that so many different proteins could all bind directly to GAPR-
1. Rather, we explored the possibility that several of these proteins belong to a 
large complex that binds the column due to an interaction of one (or more) of its 
protein components with GAPR-1. To analyze this possibility, 10ml of CHO 
cytosol (20mg/ml) were separated into two pools by gel filtration. By use of a pre-
calibrated Superdex 200 column (26mm x 70cm), a pool containing proteins with 
a molecular mass higher than 100kDa (HMW), and another pool with proteins 
lower than 100kDa (LMW) were obtained (Fig 16, panel A). These two pools 
were loaded separately onto a GAPR-1wt affinity column, and after extensive 
washing, a sodium chloride gradient was applied. SDS-PAGE analysis of the 
eluted proteins (Fig. 16, panel (B)) showed that several proteins in the HMW 
fraction bound to the column. In contrast, only a very weak band is observed to 
bind from the LMW fraction.  
 
These results indicate that proteins binding to GAPR-1 affinity column are at 
least partially present in a large complex in the cytosol. In addition, this result 
shows a protein pattern similar to that observed for total cytosol (Fig. 13), 
suggesting that the same complex binds in both cases. Of note, the intensity of 
the bands eluted from the column loaded with HMW cytosol is lower as 
compared to the intensity of bands eluted after loading with whole cytosol (Fig. 
13). This is probably due to dilution of the cytosolic components in the gel 
filtration.  
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Figure 16. GAPR-1 association to a 
cytosolic complex. Panel (A) shows 
separation of 10 ml CHO cytosol (20 mg/ml) 
in buffer (50 mM Tris-HCl, pH 7.5; 50 mM 
NaCl) on a pre-calibrated Superdex 200 gel 
filtration column (see Material and Methods). 
Collected fractions were combined in two 
different pools: a pool containing proteins 
above 100kDa (HMW pool), and a pool 
containing proteins below 100kDa (LMW 
pool). Panel (B) shows a SDS-PAGE 
analysis of peak fractions eluting from 
GAPR-1wt affinity column, after loading with 
different cytosolic pools:  Lane 2, Fraction 
14 (peak fraction Fig. 10, panel A); Lane 3, 
Peak fraction eluting from GAPR-1wt affinity 
column loaded with HMW pool; Lane 4, 
Peak fraction eluting from GAPR-1wt affinity 
column loaded with LMW pool.
 
2.4.4 GAPR-1 interacting partner in vitro 
 
The above described results suggest that GAPR-1 interacts with a protein complex 
present in the cytosol. To investigate which protein(s) in the complex interact 
directly with GAPR-1, HeLa cytosol was incubated at 95oC in buffer (50 mM Tris-
HCl, 50 mM NaCl, pH 7,5) containing 1% SDS, followed by quenching with 
1%Triton X-100 to decrease the sodium dodecyl-sulphate concentration to 0,1%. 
The solution was loaded onto a GAPR-1wt affinity column at a flow rate of 
0,5ml/min, washed and bound proteins were eluted by a sodium chloride gradient. 
As a result of this treatment, the protein complex dissociated, and only 3 major 
components eluted from the column (fig. 17, lane 1). The 3 proteins were identified 
by MALDI-TOF as Nucleolin (NCL), Template Activating factor I (TAFI) and 
HSPAHPI2B. Nucleolin seems to be the major component present in the 
preparation, and its identity was confirmed by western blot analysis (Fig. 14, lane 
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3).  A similar preparation was loaded onto the GAPR-1mut column, and only a faint 
band was observed at 115kDa in the peak fraction eluting from the column (Fig. 
17, lane 2). This minor component was identified by western blot as NCL as well 
(data not shown). This result suggests that NCL, TAF1 and HSPAHP12B are 
potentially interacting partners of GAPR-1, and that the amino acids mutated in 
GAPR-1mut are essential for the interaction. Nucleolin runs around 97 to 110 on a 
12% SDS-PAGE (Gilchrist, J. S. et al. 2002), even though Nucleolin is a 76,5 kDa 
protein (Lischwe, M. A. et al. 1985). This behavior has been explained by 
phosphorylation at the N-terminus region of the protein, which might function as a 
post-translational modification mechanism for the regulation of protein function 
(Rao, S. V. et al. 1982; Peter, M. et al. 1990). Fig. 17 (Lane 1) shows a similar 
behavior for Nucleolin, both in SDS-PAGE and western blot analysis (Lane 3). 
   
 
 
Figure 17. Identification of primary interacting partners of GAPR-1. 200 ml of HELA cytosol 
(1mg/ml) were incubated at 95oC for 15 min in buffer (50 mM Tris-HCl; 50 mM NaCl) containing 
1%SDS, followed by quenching with 1,8L of buffer (50 mM Tris-HCl; 50 mM NaCl) containing 1% 
Triton X-100. The sample (2L) was loaded onto GAPR-1wt affinity column. A similar preparation 
was loaded onto GAPR-1mut affinity column. Lane 1 shows the peak fraction after elution by a 
sodium chloride gradient. Lane 3 represents a western blot analysis performed on the peak fraction 
after elution, using a Nucleolin antibody. Lane 2 shows the peak fraction after elution by sodium 
chloride gradient on a GAPR-1mut affinity column. Lane 4 shows the identity of the proteins, 
determined by MALDI-TOF. 
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3 Structural Characterization of GAPR-1 
3.1 Characterization of Recombinant GAPR-1wt  and GAPR-1 mut 
 
The mutations in GAPR-1 could have an effect on the overall structure of the 
protein. To analyze this, GAPR-1wt and GAPRmut were compared by different 
methods. Both forms of GAPR-1 (wild type and mutant) were purified to 
homogeneity. The two proteins behaved similar on cation exchange 
chromatography, and both proteins showed the same reactivity to the GAPR-1 C-
terminal antibody (α-1852). The molecular masses of the folded wt and mutant 
proteins were analyzed by size exclusion chromatography light scattering (SEC-
LS) using a pre-calibrated Superdex 200 gel filtration column. GAPR-1 has a slight 
tendency to form dimmers in solution (Fig. 18): the major peak eluting between 
17.9 and 18.2ml represents the monomeric form of GAPR-1. A small peak eluting 
between 16.8 and 17.2ml contains the homodimer form of GAPR-1wt. GAPR-1mut 
behaves different in solution and the majority of this protein elutes between 16.2 
and 16.7ml, indicative of a predominantly homodimeric form of GAPR-1mut (Fig. 
18, Inset). The second and smaller peak observed in the profile for GAPR-1mut 
represents the monomeric form of the protein. These data suggest that the 
equilibrium between monomeric and dimeric forms of the protein in solution has 
been altered by the mutation, creating conditions for GAPR-1mut to be present 
mostly as a homodimer in solution. This might explain that the conditions used so 
far for crystal formation of GAPR-1wt were not suitable for GAPR-1mut and that 
dimerization of the protein may effect crystal formation of GAPR-1mut. 
3.2 GAPR-1/GAPR-1 interaction in vivo 
To determine whether GAPR-1 can form dimers on Golgi membranes, isolated 
CHO Golgi membranes were crosslinked with N-Hydroxylsulfonsuccinumydyl-4-
azidobemzoate, similar as described in section 1.4. Upon immunoprecipitation of 
lysates using antibodies against GAPR-1, an irradiation-dependent cross-link 
product appears at 34kD when the immunoprecipitates were analyzed for the 
presence of GAPR-1 (Fig. 19). These data suggest that GAPR-1 is present as a 
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dimer on the Golgi membrane (Fig. 19). However, it does not exclude the 
possibility GAPR-1 interacts with an unknown protein of similar molecular mass.  
 
 
 
 
 
Figure 18. Size-exclusion chromatography (SEC-LS) of GAPR-1wt and GAPR-1mut. 200µl 
samples of pure GAPR-1wt or GAPR-1mut (100µg/ml) were subjected to size-exclusion 
chromatography at 8oC in a buffer containing 50mM Tris-HCl, pH 8.0 and 300mM NaCl. The 
concentration of GAPR-1wt and GAPR-1mut in sample loaded on the column was 0.3mM. Elution 
profile of GAPR-1wt (black line): the peak of absorbance at 280 nm eluted between 17.9 and 
18.2ml for GAPR-1wt (monomer). The peak eluted between 16.8 and 17.2ml represents a 
homodimer form of GAPR-1wt.  Elution profile of GAPR-1mut (red line): The peak of absorbance 
at 280 nm eluted between 16.2 and 16.7ml for GAPR-1mut (homodimer), and the peak eluted 
between 17.3 and 17.6ml for the monomer form of GAPR-1mut. Inset shows the calculated molar 
masses of the proteins eluting from the pre-calibrated Superdex200.  
 
 
 
Results 
 46
 
 
 
Figure 19. GAPR-1 dimerization on Golgi membranes. CHO Golgi membranes (50µg) were 
incubated with N-Hydroxylsulfosuccinimidyl-4-azidobenzoate (5mM) in PBS for 30 minutes at RT 
and left on ice (lane1, and 4) or irradiated for 10 minutes at 254 nm (lane 2 and 5) and analyzed 
for crosslinked products. For immunoprecipitation (lane 3, and 6), 500 µg of Golgi membranes 
were used, and GAPR-1 was immunoprecipitated using an α-GAPR-1 (α1852) antibody). After 
western blotting, the PVDF membrane was incubated first with α-Caveolin-1, and subsequently 
blotted with α-GAPR-1. 
 
3.3 Circular Dichroism analysis of GAPR-1 
 
Circular dichroism (CD) spectroscopy is an important method, complementary to 
crystallography in studies of protein structure, stability and folding (Kelly, S. M. 
Price, N. C. 2000). CD spectra of proteins are usually quite complex, as they 
represent the sum of positive and negative sign contributions of backbone 
peptide groups in different conformations and aromatic side chains. Circular 
dichroism provides a possibility for defining the contribution of those residues of 
GAPR-1wt, and of replaced residues in GAPR-1mut. 
 
Fig. 20A shows far-UV (190-250nm) CD spectra of GAPR-1wt and GAPR-1mut 
in solution. Far-UV CD spectra analyses secondary structures in proteins and the 
CD spectrum of GAPR-1wt shows a negative trough in the 202-240nm region, 
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whereas GAPR-1mut shows a negative depression in the 200-240nm. Both 
curves show a similar behavior in term of secondary structural elements (α-helix, 
β-sheet): GAPR-1wt has a minimum intensity absorption in the far-UV at 208nm, 
and GAPR-1mut has a minimum at 207-208nm, whereas a positive signal is 
observed for both proteins in the range from 190-200nm. The weak negative 
signals for GAPR-1wt at 211 and 218-219nm are indicative of β-sheet forms. The 
negative signals at 208 and 224 can be assigned to α-helix structures (Kelly, S. 
M. Price, N. C. 2000). The spectrum of the GAPR-1mut, as compared to GAPR-
1wt, evidences differences in the relative amplitude of the 208nm and 224nm 
minima, probably related to slight changes in the β-sheet content. Nevertheless, 
there appears to be no major differences between GAPR-1wt and GAPR-1mut in 
α-helix, and β-sheet content.  
 
Changes in the tertiary structure can be highlighted by examining the near CD 
spectra. Fig. 20B shows near-UV CD spectra of wild-type and mutant GAPR-1. 
Differences in shape and intensity of the near-UV signals correlate with the 
different contents of aromatic amino acid residues. Analysis of amino acid 
sequence revealed that GAPR-1 contains  five tyrosine (Tyr-20, Tyr-42, Tyr-72, 
Tyr-84, Tyr-90), three tryptophan (Trp-69, Trp-83, Trp-109), eight phenylalanine 
(Phe-9, Phe-92, Phe-97, Phe-104, Phe-128; Phe-134, Phe-144, Phe-145), and 
five histidine residues (His-10, His-17, His-24, His-54, His-103). Signals in the 
region from 250-270nm are attributable to phenylalanine residues, and they 
seem to be the major determinants of the near-UV spectra. It appears that their 
positioning is altered due to the mutation in GAPR-1 (Fig. 20B). Based on the 
crystal structure, Phe-134 and Phe-144 seem to be most exposed to solvent, and 
have the fewest inter-residue contacts of all aromatic amino acids in GAPR-1. 
The presence of significant near-UV signals is a good indication that the protein 
is folded into a well-defined structure (Kelly, S. M. Price, N. C. 2000). Changes in 
the near-UV spectrum of GAPR-1mut (Fig. 20B) could be explained by the 
formation of GAPR-1mut homodimers in solution, which represents the major 
component as shown by SEC-LS. Therefore it is reasonable to assume that the 
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tertiary structure is retained. The differences of intensity in the near-UV spectra 
between 270 -290nm (Fig. 20B) suggest the presence of a Tyr residue in the 
monomer that has been perturbed by dimer formation. The major changes in 
intensity of near-UV spectrum for GAPR-1mut (between 270-290 nm) suggest 
that the tyrosine environment at the interface in the homodimer has been altered 
(Fig. 20B). 
 
 
 
Figure 20. Circular dichroism spectra for GAPR-1wt and GAPR-1mut. Far UV-spectra (CD) 
of GAPR-1wt in 5mM Phosphate buffer, pH 8.0 (black line), and GAPR-1mut in the same buffer 
(red line) in the far-UV (A) and the near-UV (B). Graphs obtained by Dr. Valerie Paneels using 
Sigma Plot®. 
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4 Interaction Trap or two hybrid system 
4.1 Nucleolin- GAPR-1 interaction.  
To extend the results of the in vitro interaction assays, studies were carried out 
using the yeast two-hybrid system to determine whether Nucleolin and GAPR-1 
can interact under in vivo conditions and also to confirm the interaction by an 
independent method. For this purpose, Nucleolin was fused to the Escherichia 
coli B42 activation domain of the prey plasmid pJG4.5 to produce pJGNCL. 
GAPR-1 (wild-type or mutant) was fused to the lexA DNA-binding domain 
sequence of the bait plasmid pEG202 to produce pEGGAPR-1wt and 
pEGGAPR-1mut. Vice versa, Nucleolin and GAPR-1 were also cloned in 
pEG202 and pJG4.5, respectively to yield pEGNCL, and pJGGAPR-1wt -or 
pJGGAPR-1mut. In the pJG4.5 construct, expression of the B42 fusion construct 
is repressed by glucose and induced by galactose. The two plasmids were 
introduced into Saccharomyces cerevisiae strain EGY48 containing the reporter 
plasmid pSH18-34. Thus, the plasmid expressing the LexA-fused bait protein 
activates a reporter system responsive to transcriptional activation through the 
LexA operator (Fig. 21). Transformants were tested for the production of β-
galactosidase as a phenotype indicative of interaction between the two fusion 
proteins. Strains harboring both plasmids grew on medium lacking leucine, uracil, 
and triptophane (Fig. 21B). Discrimination based on color is achieved when yeast 
is grown on medium containing X-gal (Fig. 21A). Expression of either fusion 
protein in combination with empty complementing plasmid resulted in a non-
interactive phenotype (data not shown). GAPR-1wt strongly induced transcription 
of the β-galactosidase reporter gene when tested against Nucleolin (Fig 22A, 
panel 1 and 2). GAPR-1mut (mutations in His54, Ala; Glu65, Ala; Glu86, Ala; 
His103) showed a decreased level of interaction (Fig. 22A, panel 3 and 4), 
implying these amino acid residues contribute to the interaction of GAPR-1 and 
Nucleolin. The reverse combination, Nucleolin (LexA) induced transcription of the 
reporter gene was somewhat less efficient when tested against GAPR-1 (B42) 
(Fig. 22A, panel 1 versus 2 respectively), and a similar effect is observed for 
GAPR-1mut (Fig. 22A, panel 3 versus 4, respectively).  In agreement with the 
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tendency of GAPR-1 to form dimers, GAPR-1wt activated the β-galactosidase 
reporter gene when tested against GAPR-1wt or GAPR-1mut. Any combination 
of GAPR-1 (wild type or mutant) in the prey and bait plasmid showed an 
interaction in the two hybrid system (Fig. 22A, panels 5-8). These results suggest 
that the mutation does not have a significant effect on GAPR-1/GAPR-1 
interaction, consistent with the results observed by size exclusion 
chromatography.  
 
 
 
 
Figure 21. Schematic representation of the two hybrid system assay. (A) An EGY48 yeast 
cell containing the LexA operator-responsive reporter, and the plasmid bearing the GAL1 
promoter-lacZ fusion gene (causing yeast to turn blue on medium containing Xgal). (B) A positive 
interaction is shown between GAPR-1 and Nucleolin, fused to the B42 acid blob (domain) in 
pJG4.5, resulting in the activation of the operator by the reporter LexA fused to GAPR-1, thus 
causing a blue color on medium containing X-gal. Symbols: blue rectangle, LexA operator 
sequence; green circle, LexA protein; open pentagon, GAPR-1; open bent rectangle, Nucleolin; 
red box, activator protein B42 (acid blob). 
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Figure 22. Interactions between GAPR-1 (wild-type and mutant) and Nucleolin.  Strains of 
Saccharomyces cerevisiae EGY48 harboring interaction constructs of the bait plasmid pEG202 
and the prey plasmid pJG4-5, containing GAPR-1wt, GAPR-1mut or Nucleolin as indicated, were 
tested for growth (panel B) on medium containing: glucose, without leucine, tryptophan and uracil, 
and X-gal (panel A). Positions represent the growth patterns of strains expressing: 1) GAPR-1wt 
(pGEGAPR-1wt) + Nucleolin (pJGNCL); 2) GAPR-1wt (pJGGAPR-1wt + Nucleolin (pEGNCL); 3) 
GAPR-1mut (pEGGAPR-1mut) + Nucleolin (pJGNCL); 4) GAPR-1mut (pJGGAPR-1mut) + 
Nucleolin (pEGNCL); 5) GAPR-1wt (pGEGAPR-1wt) + GAPR-1wt (pJGGAPR-1wt); 6) GAPR-
1mut (pEGGAPR-1mut) + GAPR-1wt (pJGGAPR-1wt); 7)  GAPR-1mut (pEGGAPR-1mut)  +  
GAPR-1mut (pJGGAPR-1mut); 8) Nucleolin (pEGNCL) + Nucleolin (pJGNCL). C. Quantitation of 
Nucleolin / GAPR-1 interactions and GAPR-1/GAPR-1 in EGY48 bearing plasmids as indicated in 
panel a,b. Relative intensities were determine (intensity/mm2 arbitrary units) for each colony on X-
gal versus controls bearing empty plasmids.  
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5 Regulation of GAPR-1 expression  
5.1 Effect of serum starvation on GAPR-1 expression in CHO cells 
 
GAPR-1 is not expressed in cells tissues terminally differentiated in G0 (e.g. brain 
and skeletal muscle) (Eberle, H. B. et al. 2002), and highly expressed in tissues 
with higher turnover rate. It is known that serum starvation also induces cells to 
arrest in the G0/G1 phase of the cell cycle in cell cultures (Cooper, S. 2003). To 
investigate a possible effect of serum starvation on GAPR-1 expression, CHO 
cells at 70-80% confluence were transferred to serum free medium and grown for 
various periods of time (0, 3, 9 and 48 hrs). After each incubation period, the 
cells were lysed and a total membrane fraction was obtained. Western Blot 
analysis (Fig. 23 upper panel A) shows the effect of serum starvation on GAPR-1 
expression and indicates that the protein is completely down-regulated after 
48hrs when cells have entered the G0/G1 phase. This observation suggests that 
expression of GAPR-1 may be induced at a specific stage of the cell cycle and 
that the down regulation of GAPR-1 could be associated with the entry of cells 
into G0. A different type of regulation occurs for Caveolin-1 (Fig. 23 panel A). It is 
known that caveolin is up-regulated in G0/G1 (Volonte, D. et al. 2002) (Galbiati, F. 
et al. 2001), and as expected, increased expression of this protein was observed 
after 48 hrs under serum deprivation conditions.   
5.2 Localization of Nucleolin to Golgi membranes 
 
Nucleolin has been reported as a nucleolar protein in eukaryotic cells (Ginisty, H. 
et al. 1999), but is has also been found in the cytoplasm (Srivastava, M. Pollard, 
H. B. 1999) and at the cell surface (Hovanessian, A. G. et al. 2000). In order to 
investigate whether Nucleolin can localize to the Golgi apparatus, sub-cellular 
fractionation of HeLa cells and rat liver was performed to obtain Golgi 
membranes and a cytosolic fraction. The presence of Nucleolin was determined 
by immunoblotting using a commercially available antibody against Nucleolin 
(Fig. 24). This antibody cross-reacts with human and rat Nucleolin. Interestingly, 
this Nucleolin antibody is able to recognize a band at 110kDa, which represents 
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Nucleolin in the HeLa Golgi (Fig. 24, lane 2), as well as in the cytosol (Fig. 24, 
lane1). In rat liver Golgi, Nucleolin could not be detected (Fig. 24, lane 4), 
although Nucleolin is present in rat liver cytosol (Fig. 24, lane 3). These blots 
were analyzed for GAPR-1 to confirm its localization to the same compartments. 
As shown in Fig. 24 (lane 2 and 4), GAPR-1 is present in the Hela Golgi (Fig. 24, 
lane 2), but absent from rat liver Golgi (Fig. 24 lane 4). This result confirms 
previous findings (Eberle, H. B. et al. 2002) (Eisenberg, I. et al. 2002), where 
GAPR-1 could not be detected in liver membranes, both by immunoblotting and 
by mRNA detection (Eisenberg, I. et al. 2002). Unfortunately, it was not possible 
to use CHO Golgi membranes in these experiments, since the Nucleolin antibody 
does not react with the hamster version of the protein.  
 
 
 
 
Figure 23. Effect of serum starvation on GAPR-1 expression in CHO cells. A. CHO cells at 
70-80% confluence were incubated in serum-free α-DMEM  for different time periods (0, 3, 9 and 
48 hrs). Cells were harvested and lysed in Tris-HCl pH 7.5; 200mM Sucrose (as described in 
Materials and Methods). Total membranes were obtained from the post nuclear supernatant by 
centrifugation at 100,000 xg, 1hr. 25µg of total protein were separated by SDS-PAGE (14%), and 
analyzed by western blotting. PVDF membranes were first incubated with α-GAPR-1 (α-1852), 
followed by α-Actin, and α-Caveolin-1. B.  Relative intensities of GAPR-1 expression were 
determined (intensity/mm2 arbitrary units) for each band using the software Quantity One® 
(Biorad) and plotted versus incubation times.  
Results 
 54
 
 
 
 
 
 
 
 
Figure 24. Nucleolin localization on Golgi membranes. Golgi membranes and cytosol were 
obtained from HeLa cells as indicated in Materials and Methods. 20µg of total Golgi membranes 
or 20µg cytosolic proteins were separated by SDS-PAGE, and analyzed by western blot for the 
presence of Nucleolin and GAPR-1 using specific antibodies against these proteins (C23 
(Nucleolin) and α-1852, respectively). 
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Discussion 
GAPR-1 is a novel human protein that belongs to Group 1 of the plant 
pathogenesis-related proteins, a superfamily of proteins sharing structural 
similarities (Murphy, E. V. et al. 1995; Yamakawa, T. et al. 1998). Although an 
antifungal activity has been described for plant members of the superfamily 
(Antoniw, J et al., 1980), little is known about their function. Recent evidence 
suggests, however, a more general role in signaling during host-pathogen 
interactions in plants. This may suggest a role in the (innate) immune system 
for mammalian family members, which is reminiscent of the plant immune 
system. 
1  Binding of GAPR-1 to Golgi membranes 
GAPR-1 was originally identified in a low-density detergent-insoluble fraction 
(GICs) from a Golgi-enriched fraction  (Gkantiragas, I. et al. 2001). The 
presence of GAPR-1 in these lipid-enriched microdomains implies a strong 
membrane association of the protein, and  several lines of evidence suggest 
that GAPR-1 is tightly bound to membranes (Fig. 7) (Eberle, H. B. et al. 2002). 
Here, several characteristics of GAPR-1 were investigated, which may be 
involved in the membrane binding of GAPR-1.  
1.1 GAPR-1 binding to membranes 
GAPR-1 contains the consensus sequence for N-myristoylation, which is the 
substrate for N-myristoyl- transferase, as has been shown in vitro (E. coli) 
(Fig. 5). Native GAPR-1 was found to be myristoylated by mass spectroscopic 
analysis (Fig. 6). For many proteins, the myristate chain is required for 
membrane binding, which in turn is required for proper cellular function 
(Zheng, J. et al. 1993). It has been suggested that fatty acylation –
myristoylation and/or palmitoylation- may represent a common mechanism for 
targeting cytoplasmic molecules to caveolae or other membrane domains 
(Lisanti, M. P. et al. 1994). However, it is unlikely that N-myristoylation is the 
only motif for membrane binding in GAPR-1, since the binding energy of 
myristate to membranes is not sufficient to stably anchor a protein to a 
membrane (Peitzsch, R. M. McLaughlin, S. 1993). In support of this, several 
Discussion 
 
 
 56
myristoylated proteins do not show exclusive membrane localization 
(McCabe, J. B. Berthiaume, L. G. 2001). Therefore, a second interaction is 
required for efficient membrane-binding of myristoylated proteins (reviewed in 
Resh, M. 1999). The two-signal model for membrane binding of N-
myristoylated proteins -defined as either a polybasic cluster of amino acids  or 
a palmitate moiety- (Resh, M. D. 1999) (Fig. 25) could explain the binding of 
GAPR-1 to membranes. As GAPR-1 is expected to be highly charged at 
physiological pH (pI=9.4), electrostatic interactions could provide an additional 
anchoring signal as it has been shown for MARCKS proteins (McLaughlin, S. 
Aderem, A. 1995). GAPR-1 has positive clusters of amino acids both at the N- 
and C-terminus which could be involved in binding to Golgi membranes. Thus, 
the interaction of GAPR-1 with membranes is proposed to occur via positive 
residues (Lys-Arg) (Kim, J. et al. 1991), and a myristate group. Non-
myristoylated recombinant GAPR-1 is able to interact with many types of 
membranes such as liver Golgi membranes and peroxisomes that do not 
contain endogenous GAPR-1 (data not shown); these interactions are likely 
due to electrostatic interactions properties of the protein with membranes.  
 
 
Figure 25. The two-signal model for membrane binding of myristoylated proteins. 
Myristoylated proteins require a second membrane binding signal. A cluster of basic residues 
can provide electrostatic interactions with acidic phospholipid head groups at the inner leaflet 
of the bilayer (myristate + basic). One or two palmitate moieties can provide additional 
hydrophobic interactions with the bilayer (myristate + palmitate). Alternatively, membrane 
interaction of singly acylated proteins can be enhanced by protein-protein interactions with 
other membrane-bound proteins (Resh, M. D. 1999).  
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According to the two-signal model for membrane-binding, protein-protein 
interactions could be involved in membrane-binding of GAPR-1 as well. 
Proteins belonging to the GICs such as B subunit of the vATPase, flotillin-1, 
caveolin and GAPR-1 interact with each other after disruption of the 
microdomain scaffold (Gkantiragas, I. et al. 2001). These results suggest that 
the lipid scaffold may not be absolutely necessary for membrane-binding of 
GAPR-1. In this work it is reported that GAPR-1 interacts directly with 
caveolin-1 (Fig. 7, and Eberle, H. B. et al. 2002). This interaction is possibly 
mediated via a potential caveolin-binding motif (Okamoto, T. et al. 1998), 
although this remains to be addressed. However, the interaction of GAPR-1 
with Caveolin does not clarify the lipid raft localization of GAPR-1: in contrast 
to caveolin-1, GAPR-1 has not been detected at the plasma membrane, which 
is the major site of caveolin localization. Nonetheless, Caveolin-1 does exist 
at the trans-Golgi network and earlier compartments (Gkantiragas, I. et al. 
2001; Fielding, C. J. Fielding, P. E. 2003). 
Alternative to the two-signal model it is possible that an N-myristoyl group 
plays a structural role to stabilize a protein conformation on the membrane 
(Zheng, J. et al. 1993), In this case, GAPR-1 binds the membrane by its 
electrostatic and protein-protein characteristics, and the myristate-group 
would determine its conformation on the membrane. It is also possible that 
GAPR-1 is subject to a “myristoyl switch”, triggered by electrostatic and 
protein-protein interactions, which can affect the membrane binding (reviewed 
in Resh, M. D. 1999). The myristoyl-switch can be activated by ligand binding 
(ADP-ribosylation factor), by electrostatic interactions (MARKCS) 
(McLaughlin, S. Aderem, A. 1995) or by proteolysis (Zhou, W. et al. 1994).  
1.2 A possible role of phosphorylation in membrane partitioning of 
GAPR-1? 
 
Dynamic partitioning of selected proteins to lipid microdomain appears 
necessary to provide rapid, efficient, and specific propagation of stimuli to 
targets (Oh, P. Schnitzer, J. E. 2001) (Prior, I. A. Hancock, J. F. 2001). 
Phosphorylation of proteins can e.g. control their interaction to other proteins, 
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their location in the cell, and their propensity for degradation by proteases. 
Sawai, T. et al., (1993) have shown that phosphorylation of MARCKS – an N-
myristoylated protein- moves it reversibly off the membranes, implying a 
mechanism to control the reversible binding of myristoylated proteins to 
membranes. For MARCKS the mechanism is understood to some extent, 
since phosphorylation occurs to the calmodulin-binding domain of MARKCS, 
a basic cluster that also binds to acidic lipids in membranes. GAPR-1 does 
not have the same positive cluster arrangement as MARCKS, but 
phosphorylation of GAPR-1 may change its partitioning to membranes (Fig. 
26). Phosphorylation experiments show that highly phosphorylated GAPR-1 is 
present in cytosol. Phosphorylation of GAPR-1 is, however, not restricted to 
the cytosolic pool and the largest pool of phosphorylated GAPR-1 is found in 
lipid microdomains. Given the high amounts of GAPR-1 molecules in 
microdomains, the degree of phosphorylation per molecule of GAPR-1 seems 
however, lower. Since the level of phosphorylation seems dissimilar between 
different pools, phosphorylation might allow GAPR-1 to distribute between 
different compartments within the cell i.e. the raft fraction, the non-raft fraction, 
and cytosol. Phosphorylation of GAPR-1 could effect the electrostatic 
interactions with membranes, similar as for the MARCKS proteins 
(McLaughlin, S. Aderem, A. 1995; Resh, M. D. 1999).  Phosphorylation could 
also affect the conformation of GAPR-1, thus affecting its partitioning to 
different pools. A conformation-dependent microdomain localization has been 
described for H-ras (Prior, I. A. et al. 2001). GTP loading shifts this equilibrium 
to the fluid phase membrane. The exact mechanism is unknown, but it is 
believed that GTP loading causes a conformational change, which is 
transmitted through to the membrane anchor to reduce lipid microdomain 
affinity.  
1.3 Alternative roles of phosphorylation of GAPR-1 
 
Many proteins are degraded upon phosphorylation (Johnson, G. L. Lapadat, 
R. 2002). Serum starvation conditions -used to treat CHO cells for different 
periods of time (3, 6, 9, 24 and 48 hrs) - cause a proliferative arrest in G0/G1 
(Cooper, S. 1998; Cooper, S. 2003) (Fig. 23). During this process, GAPR-1 is 
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down-regulated. This is in agreement with the differential expression of 
GAPR-1 in various tissues. GAPR-1 is absent in tissues terminally 
differentiated (brain and skeletal muscle) (Eberle, H. B. et al. 2002). In other 
types of cells, including some lymphocytes, GAPR-1 is highly expressed. The 
experimental conditions used for phosphorylation induces arrest in G0/G1. It 
has been proposed that cells are able to enter the G0 phase at the instant of 
starvation (Zetterberg, A. Larsson, O. 1985). Thus, GAPR-1 phosphorylation 
may result in release from the membrane and subsequent degradation. 
 
 
 
Figure 26. Schematic view of the GAPR-1 partitioning to Golgi membranes and 
phosphorylation. GAPR-1, located to Golgi microdomains, may distribute differentially upon 
phosphorylation. Highly phosphorylated GAPR-1 localizes to the lipid rafts and cytosol, 
whereas a low phosphorylated fraction seems to be membrane bound but non-raft 
associated. The scheme also depicts GAPR-1 interaction with Caveolin-1. Symbols: red 
hairpin shape, Caveolin-1; blue nudge shape, GAPR-1; red circles, phosphate-groups 
(phosphorylation).   
 
 
 Phosphorylation could also regulate GAPR-1 interaction with Caveolin-1. This 
might affect GAPR-1 activity, as has been proposed for other caveolin 
interacting proteins (Smart, E. J. et al. 1999): Caveolin-1 can suppress 
GTPase activity of heterotrimeric G proteins and it inhibits kinase activity of 
Src family tyrosine kinases.  Inhibition occurs via the caveolin-binding domain, 
which is also present in GAPR-1.  In all cases, the caveolin-binding motif is 
located within the enzymatically active catalytic domain of a given signaling 
molecule (Smart, E. J. et al. 1999). In GAPR-1 the caveolin-binding domain is 
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not located within the cleft suggested to be a potential active center, but rather 
exposed to the exterior of the molecule (Fig. 11). This implies a distinct 
mechanism of regulation.  
 
Preliminary studies show an inverse correlation between the expression of 
GAPR-1 and Caveolin-1 in CHO cells. As shown before, GAPR-1 expression 
is up-regulated in cell lines and tissues with a high turnover (Eberle, H. B. et 
al. 2002). On the other hand, Caveolin-1 expression is down regulated in 
human tumors, in cell lines derived from human tumors, and in cell lines 
transformed by oncogenes (reviewed in Volonte, D. et al. 2002). It is been 
suggested that Caveolin represents a candidate protein in mediating cellular 
senescence, and it is known that overexpression of Caveolin-1 in mouse 
embryonic fibroblast is sufficient to lock these cells in the G0/G1 phase of the 
cell cycle (Galbiati, F. et al. 2001). This implies that Caveolin-1 mediates cell 
cycle arrest.  The cell cycle arrest has a differential impact on the expression 
of both proteins: GAPR-1 is down-regulated, whereas Caveolin-1 is up-
regulated (Fig. 23). If GAPR-1 is a signaling molecule, then Caveolin may 
function as a negative regulator to inhibit its activity, as has been suggested 
for other signaling molecules with Caveolin-binding motif (Okamoto, T. et al. 
1998). 
2 Structure function-relationship of GAPR-1 
2.1 GAPR-1and the superfamily of the plant pathogenesis-related 
proteins 
 
Sequence alignment of GAPR-1 (Fig. 27) shows significant homology and 
identity with members of the plant pathogenesis-related proteins (group 1). 
These proteins share typical characteristics present in most family members: 
among them are the absolutely conserved histidines (His54 and His103 in 
GAPR-1) and glutamates (Glu65 and Glu86), and the highly conserved motifs 
GENL(A) and gHyTQvVW (amino acids 64-68 and 102-109 respectively, in 
GAPR-1) (Eberle, H. B. et al. 2002). For plant pathogenesis-related protein 
(PR-1) many hypotheses have been proposed to understand the role of the 
conserved amino acid residues in family members (Fernandez, C. et al. 1997; 
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Szyperski, T. et al. 1998; Henriksen, A. et al. 2001). Szypersky, T et al. (1998) 
show that His-69 and His-127 are “solvent exposed and strictly conserved” in 
p14a (a plant PR-1 protein), and suggested that these residues are 
candidates for a role in the active site. Moreover, they stated that the two 
histidines are in close spatial proximity to the conserved glutamates 88 and 
113 concluding that these amino acids seem not to have a structural role in 
both P14a and/or GliPR. The same authors calculated that the pocket 
containing the “conserved active site” residues is the largest cleft on both 
protein surfaces (Szyperski, T. et al. 1998), suggesting that GliPR and P14a 
proteins might function as enzymes. GAPR-1 contains similar conserved 
residues (His54, His103, Glu65, and Glu86) in its structure and shows similar 
features for the cleft region together with the two other member proteins of 
this superfamily that have been studied in terms of their structures (P14a and 
Ves-v 5) (Szyperski, T. et al. 1998; Henriksen, A. et al. 2001) (Fig. 28). In 
GAPR-1 (Fig. 29), the cleft contains highly (blue) and absolutely (red) 
conserved residues found throughout the PR-1 family of proteins, which 
suggests that this region is of extreme importance for the role of this group of 
proteins.  
 
What is known about possible functions of family members? In plants, PR-1 
proteins are synthesized upon interaction with pathogens. Mammalian family 
members are present in e.g. snake venom (Morrissette, J. et al. 1995; 
Yamazaki, Y. et al. 2002) or produced in reproductive organs and cells 
(Kasahara, M. et al. 1989). The only indication for a biological function of the 
mammalian family members has been i) the weak trypsin-inhibiting effect of 
GliPR, ii and iii) the blocking by the toxin helothermine of the ryanodine 
receptors and of the high K+-induced contraction of the artery. So far GAPR-1 
is the only intracellular member of the PR-1 family with a tight membrane 
association. It lacks the signal sequence present in other PR-1 family 
members, resulting in an intracellular localization of the protein (Eberle, H. B. 
et al. 2002). The plant pathogenesis-related proteins have been implicated in 
a mechanism of defense against pathogen attacks of plants (Heil, M. Bostock, 
R. M. 2002) (Van Loon, L; Van Strien, E. 1999). Interestingly, GAPR-1 not 
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only localizes to the Golgi, but also to other membrane structures within the 
cell, such as phagosomes that are also involved host-pathogen interactions 
(Dora Kaloyanova unpublished data).  
 
GAPR-1    1 --MGKSAS--KQFHN--------------------------------------------- 
CG2337    1 --MGYLSAPIKHAHNKSSSRAQIDILQPKTRNQSHAEDKVSSTSPCSSCFFAPAAAAVSK 
PR1       1 MKVIYCSRLLLILAALVG------------------------------------------ 
PRY1      1 MKLSKLSILTSALATSALAAPAVVTVTEHAHEAAVVTVQGVVYVENGQTRTTYETLAPAS 
AG5       1 NNYCKIKCLKGGVHTACKYESLKPNCAN-------------------------------- 
TPX1      1 MALLPVLFLVTVLLPSLPAEGKDP------------------------------------ 
GliPR     1 --MRVTLATIAWMVSFVSNYSHTAN----------------------------------- 
 
GAPR-1   12 ------------------------------------------------------------ 
CG2337   59 ATDIVVNDDGPRHQPHVWEPELVPPQSALAHGWQSQTFIATAPWSNSENLISGWGVAPLE 
PR1      19 ---------------------------ALVHPSRAQ------------------------ 
PRY1     61 TATPTSTATALVAPPVAPSSASSNSDVVLSALKNLASVWG-------------------- 
AG5      29 -----------------------KKVVAYGLTKQEK------------------------ 
TPX1     25 -----------------------AFTALLTTQLQVQR----------------------- 
GliPR    24 ---------------------------ILPDIENED------------------------ 
 
GAPR-1   12 ------------------------------------------------------------ 
CG2337  119 LVRCCWRSELIALSFGLCLCEVICQYPNAKSMKPQASCQHNKQIAAEASVLRQLDFFDME 
PR1      28 -----------------N------------------------------------------ 
PRY1    101 ----------KTTDSTTTLTSSESTSQSLAQATTTSTPAAASTTSTPAATTTTSQAAATS 
AG5      42 ------------------------------------------------------------ 
TPX1     39 ------------------------------------------------------------ 
GliPR    33 ------------------------------------------------------------ 
 
GAPR-1   12 --------------EVLKAHNEYRQKHG-----------VPPLKLCKNLNR--EAQQYSE 
CG2337  179 KPLSLVLVIADLQEDHLNEHNRLREKHG-----------SPPLTLDDELTK--GCEEYAK 
PR1      29 ---SP--------QDYVNAHNQARQAVG-----------VGPVQWDGTLAA--FAQSYAD 
PRY1    151 SASSSDSDLSDFASSVLAEHNKKRALHKD----------TPALSWSDTLAS--YAQDYAD 
AG5      42 -------------QDILKEHNDFRQKIARGLETRGNPGPQPPAKNMKNLVWSDELAYIAQ 
TPX1     39 --------------EIVNKHNELRKAVS------------PPASNMLKMEWSREVTTNAQ 
GliPR    33 -----------FIKDCVRIHNKFRSEVK------------PTASDMLYMTWDPALAQIAK 
 
GAPR-1   45 ALASTRILKHSPE---SSRGQ-----CGENLAWASY----DQTGKEVADRWYSEIKNYNF 
CG2337  226 VLANNEKLEHSSS---AGQN------YGENLCMRS------QTPLQCVQDWYDEIADYDF 
PR1      65 RLRGDCRLVHS-------GGP-----YGENLAWSSA----DFSGVSAVNLWVNEKANYNY 
PRY1    199 NYDCSGTLTHS-------GGP-----YGENLALGY-------DGPAAVDAWYNEISNYDF 
AG5      89 VWANQCQYGHDTCRD-VAKYP-----VGQNVALTGSTAAKYDNPVKLVKMWEDEVKDYNP 
TPX1     73 RWANKCTLQHSDPEDRKTSTR-----CGENLYMSSD----PTSWSSAIQSWYDEILDFVY 
GliPR    70 AWASNCQFSHNTRLKPPHKLHPNFTSLGENIWTGSVP---IFSVSSAITNWYDEIQDYDF 
 
GAPR-1   93 QQPGFTSGTG---HFTAMVWKNTKKMGVGKASAS--------DGSSFVVARYFPAGNVVN 
CG2337  271 EKPQFAMSTG---HFTALVWKNAKKMGIGQAKDK--------KGYYWVVARYYPPVNVN- 
PR1     109 ASNTCINGECR--HYTQVVWRKSVRIGCGKARCN--------NGGTIISCNYDPRGNYVN 
PRY1    240 SNPGFSSNTG---HFTQVVWKSTTQVGCGIKTCGG-------AWGDYVICSYDPAGNYEG 
AG5     143 KKKFSENNFLKIGHYTQMVWANTKEVGCGSIKYIQDK-----WHKHYLVCNYGPSGNFGN 
TPX1    124 GVGPKSPNAVVG-HYTQLVWYSTYQVGCGIAYCPNQD-----SLKYYYVCQYCPAGNNMN 
GliPR   127 KTRICKKVCG---HYTQVVWADSYKVGCAVQFCPKVSGFDALSNGAHFICNYGPGGNYPT 
 
GAPR-1  142 EG--FFEENVLPPKK--------------------------------------------- 
CG2337  319 -G--QFEENVLPPIKGEGDENGQGNLNRFQVDNIPIIVMLWLCWQFTN------------ 
PR1     159 EK--PY------------------------------------------------------ 
PRY1    290 ----EYADNVEPLA---------------------------------------------- 
AG5     198 EE--LYQTK--------------------------------------------------- 
TPX1    178 RKNTPYQQGTPCAGCPDDCDKGLCTNSCQYQDLLSNCDSLKNTAGCEHELLKEKCKATCL 
GliPR   184 WP---YKRGATCSACPNNDKCLDNLCVNRQRDQVKRYYSVVYPGWPIYPRNRYTSLFLIV 
 
GAPR-1      -------------------------- 
CG2337      -------------------------- 
PR1         -------------------------- 
PRY1        -------------------------- 
AG5         -------------------------- 
TPX1    238 CENKIY-------------------- 
GliPR   241 NSVILILSVIITILVQLKYPNLVLLD 
 
 
Figure 27. Amino acid sequence alignment of GAPR-1 with relatives of the superfamily 
of plant pathogenesis-related proteins (PR-1). For each of the subfamilies, including human 
GliPR, CRISPs, plant PR-1 proteins, allergens of insect venom and snake or lizard venoms, 
the protein sequence of the member with the highest homology to GAPR-1 is aligned to GAPR-
1. Identical amino acid residues in family members are highlighted in black. Conservative 
amino acid exchanges are highlighted in grey. 
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Figure 28. Comparison of the three-dimensional structure of GAPR-1, p14a (PDB entry 
1CFE) and Ves v 5 (PDB entry 1QNXA), members of the plant pathogenesis-related 
group 1 (PR-1).  a, The overall structure of P14a tomato (left) is closely related to the 
structure of GAPR-1 (center) and Ves V 5 (right). Figures prepared by Dr. Matthew Groves, 
using MolScript® software (Kraulis, P. 1991). 
 
In plants, interaction with viruses, bacteria or fungi will elicit a set of localized 
responses in and around the infected host cells. These responses include an 
oxidative burst (Heil, M. Bostock, R. M. 2002) that leads to a hypersensitive 
response (HR), and a concomitant increase in the synthesis of PR proteins 
(Klessig, D. F. et al. 2000). The oxidative response is another line of defense 
in the innate immunity, where the production of reactive oxygen intermediates 
(ROI) and reactive nitrogen intermediates (RNI) can lead to cell death 
(Kombrink, E., Schmelzer, E. 2001). High output production of reactive 
oxygen intermediaries (ROI) is the specialty of mammalian phagocytes. 
Phagocytes assemble an NAPDH oxidase complex on phagosomal 
membranes that catalyzes the production of a series of highly toxic oxygen 
derived compounds, i.e. (O2-) or nitric oxide (NO). Production of NO induces 
cell cycle arrest and cytostasis in mammalian cells (Pervin, S. et al. 2001), In 
plants, the NO and ROS production correlates with the up-regulation of the 
expression of PR proteins (Klessig, D. F. et al. 2000). This raises the question 
whether similar mechanisms may apply to GAPR-1 during the production of 
ROS and NO in mammalian cells. 
2.2 Effect of mutations on GAPR-1 structure 
 
To study the role of the most conserved amino acids present in GAPR-1, site-
directed mutagenesis was carried out to study their effect on protein 
interactions to potential cytosolic partners, as well as on the structure of 
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GAPR-1. The mutation on GAPR-1 did not significantly affect its behavior 
during purification, including GAPR-1mut purification by cation exchange 
chromatography, suggesting that the electrostatic properties were not 
changed. However, GAPR-1mut crystals did not grow when the same 
screening methods for crystallization were used. 
 
The Far-UV spectra obtained by circular dichroism revealed no major 
differences between GAPR-1wt and GAPR-1mut in their content of α-helixes 
and β-sheets. The minor changes observed in the CD spectrum (Far-UV) of 
GAPR-1mut protein (Fig. 20A) may originate from an altered content in amino 
acids residues rather than from alterations in the conformation of the 
polypeptide backbone. In Near-UV (Fig. 20B), the complex spectrum reflects 
the sum of proportion and position of the combined aromatic residues in the 
protein. As mentioned before (see Results), GAPR-1 contains several 
aromatic residues that contribute to the near-UV spectrum. It is possible that 
changes in the 250-290nm region of the spectrum are due to phenylalanines 
exposed to solvent and to tyrosines (Tyr20, Tyr72, Tyr84, and Tyr90) at the 
contact interface (Fig. 29 and 30). The distribution or positioning of these 
amino acids may have been altered by the formation of dimers. This would be 
in agreement with the CD spectra, showing equal amounts of α-helixes, and 
β-sheets. In addition, these spectra for GAPR-1 (wt and mut) reflect the 
behavior observed in size-exclusion chromatography. The tendency of GAPR-
1 to form dimers was confirmed by independent experiments. Crosslink 
experiments revealed a crosslink product at 34kDa, strongly suggesting that 
GAPR-1 is present as a dimer at the membrane. The existence of a dimer 
may have implications for GAPR-1 function. It was not possible to determine 
whether Caveolin-1 interacts with the dimer or monomer form of GAPR-1, due 
to experimental limitations of the chemical crosslinking method. 
 
The crystal structure predicts the area of interaction between the two GAPR-1 
molecules in the homo-dimer. This area (Fig. 29, right view, in blue and light-
grey) overlaps partially with the area where the highly conserved amino acid 
residues are located (Fig. 29, left view). Therefore, mutations in the highly  
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Figure 29. Structure of the GAPR-1 monomer. Left view: molecular surface representation 
of a GAPR-1 monomer with highly (blue) and absolutely (red) conserved amino acids. His54, 
His103, Glu64 and Glu86 are located in the absolutely conserved area (red); Right view: 
region of GAPR-1 potentially responsible for the interaction during dimer formation or contact 
interface (blue). Dark blue depicts region of contact during dimer formation; light blue-white 
represents regions of closer contact; red represent regions in GAPR-1 distant from the 
contact interface. The aromatic residues (Tyr20, Tyr20, Tyr84 and Tyr90) located in the 
contact interface in dimer are pointed out. Contact region in GAPR-1 includes the highly and 
absolutely conserved amino acids. Similar amino acid residues have been pointed out in 
P14a and Ves v 5 to be conserved and involved in the potential function of these proteins. 
Space-filling representations of GAPR-1 were prepared by Dr. Matthew Groves using Grasp® 
(Nicholls, A. et al. 1993). 
 
 
 
Figure 30. GAPR-1 dimer structure. GAPR-1dimer, showing the aromatic amino acids at 
the interface between the two molecules. Emphasis has been put on Tyrosine residues, 
whose contribution in circular dichroism (near-UV spectrum) may have changed in GAPR-
1mut (see Results, Fig. 17, panel B). Figure depicts Tyr20, Tyr72, Tyr84 and Tyr90, and their 
position in the dimer structure. Ribbon structure representation of GAPR-1 dimmer obtained 
by Dr. Matthew Groves using MolScript® (Kraulis, P. 1991), Raster3D® (Bacon, D. Anderson, 
W. 1988). 
 
Discussion 
 
 
 66
conserved amino acids may affect the binding forces in the contact area. 
Thus, the conserved amino acids may not only play a role in the function of 
the protein, but also in GAPR-1/GAPR-1 interactions and therefore its 
interaction with other proteins. 
 
The crystal structure of GAPR-1 shows that the active center is buried 
between the two molecules forming the dimer, since this area forms part of 
the contact interface of the protein (Fig. 30). Thus, in the dimmer the active 
center of GAPR-1 is not accessible for interaction. It is tempting to speculate 
that there is a dynamic equilibrium on the membrane between the monomer 
and dimer, where the monomer represents an “active state” (Fig. 11), and the 
dimer represents an “inactive state”. 
3 Interaction of GAPR-1 with cytosolic proteins 
 
The GAPR-1 mutant was a useful tool for identification and determination of 
potential interacting partners. The affinity chromatography elution profile of 
CHO cytosol –from both the GAPR-1 wild type and mutant columns- shows 
similar patterns in terms of proteins eluted from the columns. To increase the 
specificity of binding to the column, elutions were also performed in presence 
of 1% Triton X-100. The protein pattern obtained in those conditions was, 
however, similar to elutions without detergent treatment (data not shown). 
More protein, however bound to the wild type column and the amount seems 
to correlate with the ratio of dimer and monomer in GAPR-1wt and GAPR-
1mut (as observed by size exclusion chromatography). Since a fraction of 
GAPR-1 exists as dimer on Golgi membranes, protein-protein interactions 
occurring in the column (GAPR-1mut) could resemble the protein-protein 
interactions in vivo, where dimerization may imply a mechanism of negative 
regulation for protein interactions with GAPR-1 on the Golgi membrane. 
Peptide mass fingerprinting of proteins eluted from GAPR-1wt affinity column 
revealed an interaction with a cytosolic complex. The protein pattern appears 
similar when CHO and HELA cytosols were applied to the column (see 
Results, Table 4 and 5). Independent of the source of cytosol or pre-treatment 
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of cytosol with SDS, the major component eluting from the column is NCL 
(Fig.17). 
Nucleolin is a ubiquitous, nonhistone nuclear phospho-protein of 
exponentially growing eukaryotic cells, which runs between 100 to 115kDa 
(calculated molecular mass of 76 kD) on a 12% gel (SDS-PAGE) (Lischwe, 
M. A. et al. 1985; Ginisty, H. et al. 1999). It has been implicated in many 
cellular processes, including transcription, packing and transport of ribosomal 
RNA, replication and recombination of DNA, cell cycle progression, and 
apoptosis.(Yang, T. H. et al. 1994; Thiede, B. et al. 2001; Mi, Y. et al. 2003). 
Although generally considered a predominantly nucleolar protein, Nucleolin is 
also found in the nucleoplasm, cytoplasm, and at the cell surface (Dumler, I. 
et al. 1999; Daniely, Y. Borowiec, J. A. 2000; Wang, Y. et al. 2001). Yanagida 
and colleagues (Yanigida, M. et al. 2001) isolated and characterized the 
major NCL binding proteins in a ribonucleoprotein complex. NCL in known to 
interact to 7 ribosomal proteins that were also found in the HeLa preparation 
eluted from GAPR-1 column, and is also known to bind to the identified 
nonribosomal proteins like casein kinase 2, eIF, DNA and RNA helicases, 
and NS-1 associated protein (Yanagida, M. et al. 2001).  NCL can interact 
with about half of ribosomal proteins present in the large and small subunits 
(Yanagida, M. et al. 2001). The complex identified to bind GAPR-1 resembles 
that reported by Yanagida, M. (2001), except for a reduced amount of 
ribosomal proteins. Because NCL was reported not to bind the mature 
ribosomal particles found in the cytoplasm (Ghisolfi-Nieto, L. et al. 1996), the 
ribosomal proteins found to bind GAPR-1 are unlike to belong to mature 
cytoplasmic ribosomes and polysomes. 
 
The in vitro interaction between GAPR-1 and NCL was also observed in the 
yeast two hybrid system (Fig. 22). In addition, it was possible to determine 
that the conserved amino acids residues in the cleft of GAPR-1 play an 
important role in the interaction, since GAPR-1mut showed less activity in the 
yeast two hybrid system (Fig. 22).  Nucleolin consists of three functional 
domains, i.e. an amino (N)-terminal domain, and RNA binding domain (RBD), 
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and a carboxyl-terminal domain (RGG)  (Ginisty, H. et al. 1999). At this point it 
is unknown to which domain GAPR-1 interacts with (see also below), but the 
two hybrid system would be a suitable method to determine which Nucleolin 
domain interacts with GAPR-1.  
 
Ribonuclease activity has been suggested for P14a due to the arrangement of 
the two histidines in the putative active center (Szyperski, T. et al. 1998) and 
such an activity for GAPR-1 could make sense in the context of a large 
ribonucleoprotein complex . Preliminary experiments, however, did not show 
any evidence for such activity (data not shown). Could GAPR-1 have a RNA 
binding activity? Sequence alignment of GAPR-1 with known RNA binding 
motif (Burd, C. G., Dreyfuss, G 1994) does not show any specific similarity or 
identity.  
 
Nucleolin (NCL) expression is regulated during the cell cycle (Belenguer, P. et 
al. 1989)Derenzini, M. et al. 1995; Srivastava, M. Pollard, H. 1999). During 
G0/G1 NCL is down-regulated and localizes entirely to the nucleus. 
Concomitantly -but not necessarily related- GAPR-1 shows down-regulation at 
G0 of the cell cycle; thus, the interaction could take place when both proteins 
are simultaneously expressed. So far, NCL has not been shown to be present 
at the Golgi. Preliminary experiments show Nucleolin localization to an 
isolated, Golgi-enriched fraction (Fig. 24).This Nucleolin localization could be 
due to the presence of GAPR-1 on the same membranes, as indicated in the 
same experiment, where both Nucleolin and GAPR-1 are not present on the 
rat liver Golgi. This result opens the possibility that GAPR-1 and Nucleolin 
interact at the Golgi. Alternatively, the cytosolic pool of GAPR-1 could interact 
with cytosolic or even nuclear Nucleolin, but these experiments must be 
conducted. 
 
In addition to NCL, Template-Activating Factor I α (TAFI α) (accession no 
I59377), and an unknown protein, designated HSPHAPIB or HSAPRIL 
(accession no CAA69265) were found in the GAPR-1 affinity column after 
dissociation of cytosolic protein complex. TAFI has been identified as a 
chromatin remodeling factor in HeLa cells (Kawase, H. et al. 1996), and levels  
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HSAPRIL      1 ------------MKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVN------- 
Nucleolin    1 -----MVKLAKAGKNQGDPKKMAPPPKEVEEDSEDEEMSEDEEDDSSGEEVVIPQKKGKK 
TAFI         1 MAPKRQSPLPPQKKKPRPPPALGPEETSASAGLPKKGEKEQQEAIEHIDEVQNEIDRLNE 
 
HSAPRIL     42 LEFLSLINVGLISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPN--LTHLNLSGNKLK 
Nucleolin   56 AAATSAKKVVVSPTKKVAVATPAKKAAVTPGKKAAATPAKKTVTPAKAVTTPGKKGATPG 
TAFI        61 QASEEILKVEQKYNKLRQPFFQKRSELIAKIPNFWVTTFVNHPQVSALLGEEDEEALHYL 
 
HSAPRIL     97 DISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE--APDSD 
Nucleolin  113 KALVATPGKKGAAIPAKGAKNGKNAKKEDSDEEEDDDSEEDEEDDEDEDEDEDEIEPAAM 
TAFI       118 TRVEVTEFEDIKSGYRIDFYFDENPYFENKVLSKEFHLNESGDPSSKSTEIKWKSGKDLT 
 
HSAPRIL    153 AEVDGVDEEEEDEEGEDEED------EDDEDGEEEEFDE--------------------- 
Nucleolin  169 KAAAAAPASEDEDDEDDEDD------EDDDDDEEDDSEEEAMETTPAKGKKAAKVVPVKA 
TAFI       174 KRSSQTQNKASRKRQHEEPESFFTWFTDHSDAGADELGEVIKDDIWPN---------PLQ 
 
HSAPRIL    191 ----EDDEDEDVEGDEDDDEVSEEEEEFGLDEEDEDEDEDEEEEEGGKGEKRKRETDDEG 
Nucleolin  219 KNVAEDEDEEEDDEDEDDDDDEDDEDDDDEDDEEEEEEEEEEPVKEAPGKRKKEMAKQKA 
TAFI       229 YYLVPDMDDEEGEGEEDDDDDEEEEGLEDIDEEGDEDEGEEDEDDDEGEEGEEDEGEDD- 
 
HSAPRIL    233 EDD 
Nucleolin  275 APEAKKQKVEGTEPTTAFNLFVGNLNFNKSAPELKTGISDVFAKNDLAVVDVRIGMTRKF 
TAFI        
 
  
 
Figure 31. Sequence alignment of the potential interacting partners of GAPR-1 from 
HeLa cell cytosol. Nucleolin (accession no A35804, alignment from amino acid 1 to 345), 
Template activating factor I α (TAFI α) (accession no I59377) and HSAPRIL (accession no 
CAA69265) were identified by MALDI-TOF after elution from GAPR-1 affinity columns. 
Cytosolic complexes were dissociated by 1% SDS prior to loading on the columns (see 
Results 2.4.4). The C-terminus region of TAFI α and HSAPRIL shows the highest homology 
to the Nucleolin N-terminal domain (Yanagida, M. et al. 2001). 
 
of TAF-I protein are regulated through the cell cycle in which the chromatin 
structure is dynamically changed (reviewed in (Nagata, K. et al. 1998; 
Okuwaki, M. Nagata, K. 1998). TAFI α and β proteins differ by only a short 
amino terminal regions, but in both proteins a long acidic tail in the carboxyl-
terminal region is present (Nagata, K. et al. 1995). The acidic region is critical 
for TAF-1 activity, and the level of TAF-I activity is dependent on the length of 
the acidic region.  This C-terminal region in TAFIα shares homology with N-
terminus of Nucleolin  and is also present in HSPHAPIB/HSAPRIL (Fig. 31) 
The N-terminal domain in Nucleolin and C-terminal domain in TAFI have been 
implied as nuclear localization signals (Schmidt-Zachmann, M. S. Nigg, E. A. 
1993; Nagata, K. et al. 1998), and these regions contain multiple 
phosphorylation sites, which are regulated during the cell cycle. Little is known 
about HSAPRIL function, although it is potentially involved in Leukemia 
(Mencinger, M. et al. 1998), as it has been pointed out for TAFI (Seo, S. B. et 
al. 2001). Mouse TAFI β is ubiquitously expressed in contrast to TAFIα (i.e. 
Jurkat), which is not present in the mouse liver or brain, but is expressed in 
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spleen and lung, resembling to some extent the differential expression of 
GAPR-1 (Eberle, H. B. et al. 2002). TAFI α and TAFI β show a nuclear and 
cytoplasmic localization in HeLa cells. The function of TAFI α seem to be less 
clear as for TAFI β ((Seo, S. B. et al. 2001; Cervoni, N. et al. 2002), but there 
are some similarities with functions reported for Nucleolin.  
  
4 Perspectives of GAPR-1 function: Rafts and Nucleolin 
 
The function of GAPR-1 remains to be determined. Its potential regulation 
during the cell cycle, its interaction with other proteins such as Caveolin-1 and 
Nucleolin, as well as its presence on other membranes within the cell (i.e. 
phagosomes) can help to understand its role. 
  
The presence of GAPR-1 in phagosomes supports the premise of its potential 
involvement in the innate immunity, since phagocytosis is one of the initial 
lines of defense in animals. GAPR-1 is associated with lipid microdomains at 
the phagosomes (Dora Koloyanova unpublished data), and these 
microdomains may act as a platform to concert a specific response during 
bacterial infection. Interestingly, many other proteins found in GICs 
(Gkantiragas, I. et al. 2001) seem to be associated with phagosomes 
(Dermine, J. F. et al. 2001) as well, suggesting a possible pathway between 
the Golgi and other membrane structures within the cell. Microdomains at 
phagosomal membranes may have a role in phagosome maturation (Vieira, 
O. V. et al. 2002).  
 
There have been reports of a variety of signaling pathways associated with 
lipid rafts at the plasma membrane and other organelles (Brown, D., London, 
E. 1998). These include several signaling proteins, such as heterotrimeric G 
proteins, Ras, Src, endothelial nitric oxide synthase (eNOS), and protein 
kinase C. Many of these proteins have been reported to interact with the 
caveolin-1 scaffolding domain (Okamoto, T. et al. 1998), although it is still 
matter of debate whether this scaffolding domain in Caveolin-1 has functional 
significance. GAPR-1 is present in microdomains at the Golgi apparatus, 
along with some proteins described to interact with Caveolin-1, such as the 
Discussion 
 
 
 71
heterotrimeric G proteins (Gα subunits) (Gkantiragas, I. et al. 2001). 
Additionally, Caveolin-1 is down-regulated in transformed cells (Volonte, D. et 
al. 1999), whereas GAPR-1 seems to be up-regulated (i.e. in NRK  and AT3 
cells, data not shown). If any negative effect on GAPR-1 activity results from 
an interaction with Caveolin-1, then this may be modulated by the expression 
levels of both proteins in the cell. In phagosomes, Caveolin-1 is absent 
(Dermine, J. et al. 2001; Dora Koloyanova unpublished data), whereas 
GAPR-1 is present on the phagosomes and associated with lipid 
microdomains. In conclusion, a specific combination of proteins in protein 
complexes likely determines the final outcome of signaling pathways. Specific 
combinations of proteins in protein complexes can be regulated in several 
ways, for example by the expression levels of proteins, by containment is 
similar or different sub-cellular membranes, or even within a membrane by 
containment with lipid rafts. Based on these considerations, GAPR-1 could 
have a different function at the Golgi complex as compared to phagosomes. 
 
A GAPR-1 interaction with Nucleolin has been identified during these studies, 
but what are the implications of this interaction? Nucleolin has been 
suggested to play a role in innate immunity in mammals (Garcia, R. et al 
2000). This suggestion comes from the observation that phosphorylation of 
Nucleolin in macrophages-like cells upon infection with Mycobacterium avium. 
These studies imply that infection impaired phosphorylation of Nucleolin, and 
showed that only cytosolic Nucleolin seems to be affected. The authors 
suggested that these phosphorylation events are related to cellular apoptosis, 
and prevention of programmed cell death could result in the possibility of a 
prolonged intracellular survival of mycobacteria. It is known that the N-
terminus of Nucleolin is highly phosphorylated during the cell cycle, and 
phosphorylation affects the distribution of the Nucleolin within the cell (Ginisty, 
H. et al. 1999). If GAPR-1 interacts with the N-terminal domain in Nucleolin, 
this could imply a way to regulate phosphorylation during pathogen attack. 
The interaction between Nucleolin and GAPR-1 could occur at Golgi 
membranes (Fig. 24) and this interaction may regulate the amount of cytosolic 
Nucleolin available for phosphorylation. Nucleolin has been shown to 
Discussion 
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associate to lipid raft components at the cell surface (Nisole, S. et al. 2002; 
Said, E. A. et al. 2002) and was implicated in a mechanism of early events in 
the HIV entry process. Interestingly, Nucleolin localization to lipid 
microdomains seems to be dependent on infection, since Nucleolin in 
uninfected cells is not detergent-insoluble associated (Nisole, S. et al. 2002). 
The interaction between GAPR-1 and Nucleolin may represent a new 
mechanism of regulation of innate immunity in mammalian cells. 
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Materials and Methods 
 
Materials 
1 Chemicals 
All commonly used chemicals were purchased from either Merck (Darmstadt), 
Sigma (Deisenhofen), Roth (Karlsruhe), Fluka (Taufkirchen), Qiagen (Hilden), 
Amersham-Biotech (Freiburg), BioRad (Mϋnchen) or Boehringer (Mannheim). 
The reagents were ordered directly at the company or via the chemical centre 
Heidelberg (Theoretikum der Universität Hiedelberg).  
 
1.1 Detergents 
Triton X-100, Tween-20 and NP-40 were obtained from Merck, Sigma and 
Calbiochem, respectively.  
 
1.2 Inhibitors 
Brefeldin A was purchased from Sigma, stored in aliquots of 7.5 mM in 
methanol. The working concentration of Brefeldin A was 5 µM. Mixtures of 
protease inhibitors were obtained from Roche as tablets. Each tablet was 
sufficient for a 50 ml solution. 
 
1.3 Buffers 
A List of most commonly used buffers during this experimental work is shown 
below. All buffers were prepared as aqueous solutions. 
 
PBS buffer 
10X PBS: 1.36 M NaCl, 357 mM Na2HPO4, 143 mM KH2PO4 and 30 mM 
KCl.  PBST was obtained by mixing PBS buffer supplemented with Tween-20 
to 0.05% final concentration.  PBS was adjusted to pH 7.4. 
 
PEN buffer 
PEN buffer was prepared as a 5X stock solution, containing 125 mM PIPES, 
10 mM EDTA and 1.5 M NaCl, and adjusted to pH 6.5 with NaOH. 
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TAE buffer 
50X TAE contained 242 g Tris base, 57.1 ml of glacial acetic acid and 18.61 g 
of EDTA, and adjusted to 1 L solution with MiliQ H2O. 
 
Running buffer for electrophoresis 
10X SDS-PAGE running buffer contained 30.2 g Tris base, 188 g of glycine 
and 10 g of SDS, and adjusted to 1 L solution with MiliQ H2O.  
 
Blotting buffers for semi-dry transfer 
Anode I: 300 mM Tris and 20% (v/v) methanol. 
Anode II: 25 mM Tris and 20% methanol.  
Cathode buffer: 25 mM Tris, 40 mM aminocaproic acid and 20% methanol. 
 
Sample cocktail buffers 
Sample buffer for DNA: 6X stock solution contained 0.25% bromophenol 
blue, 40% sucrose, 60 mM Tris-HCl, pH7.4 and 6 mM EDTA.  
Sample cocktail I (SCI): 50 mM Tris-HCl pH 6.8 and 4% SDS  
Sample cocktail II (SCII): A 3X stock solution contained 187.5 mM Tris-HCl 
pH6.8, 15% β-mercatoethanol, 6% SDS, 30% glycerol and 0.0675% 
bromophenol blue. 
 
Staining Solution for SDS-PAGE 
Staining buffer: 40% ethanol, 10% glacial acetic acid and 0.25% coomassie 
blue R-250. 
Destaining buffer: 20% ethanol and 5% acetic acid. 
Ponseau S solution: prepared by adding 0.8g of the dye dissolved in 4% 
(w/v) TCA. 
 
1.4 Media 
Mammalian cells culture media 
α-MEM and DMEM were purchased from Gibco BRL (Invitrogen), 
reconstituted into water, sterilized by passing through 0.2µM filters and 
supplemented with 10% of fetal calf serum and 10 mg/ml of penicillin and 
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streptomycin.  L-Glutamine was added to both media. Non-essential amino 
acids were added to DMEM only. 
 
Bacteria and yeast culture media 
 
Luria-Bertani broth (LB) was prepared according to guidelines of Molecular 
Cloning (3rd Edition). 1 L of medium contained 10 g of sodium chloride, 10 g 
of Bacto-Trypton and 5 g of yeast extract. pH was adjusted to 7.4. For plates, 
15 g/L agar was added to the preparation. 
YPD medium was prepared as follows: 10 g of BactoYeast extract, 20 g of 
BactoPeptone and Dextrose were dissolved in 1 L of MilliQ water and 
autoclaved. 
 
SDC-URA plates 
For preparation of plates, 3,375 g of yeast nitrogen base were added to 500 
ml of MilliQ, complemented with 1 g of glucose and 0.275 g of complete 
supplement mixture (CSM) without Leucine, Triptophan, Histidine and Uracil, 
and 5 g of agar. The medium was autoclaved and poured into the plates.  
 
Xgal plates for Two Hybrid Assay  
These plates were used with the yeast strain EGY48 bearing the plasmids 
pSH18-34, pJG4.5 and pEG202. In 800 ml of MilliQ water 6.7 g of Yeast 
nitrogen base (without amino acids), 0.54 g CMS-all, and 20 g of agar were 
added. The mix was autoclaved.  Before preparing the plates, the mix was 
adjusted with a solution containing: 10 ml of 10 g/L leucine, 100 ml of 20% 
Galactose, and 10% Rafinose (preheated at 50oC), 100 ml 10X BU salts 
(preheated at 50oC), and 4 ml of 20 mg/ml X-Gal dissolved in 
Dimethylformamide.  
BU salts 10X (1 L): 261 mM Na2HPO4.2H2O; 250 mM NaH2PO4.H2O. 
The pH was adjusted to 7.0 with NaOH. pH must be controlled carefully, since 
some interactions in the two hybrid system can be affected by variations of 
0.2 pH units of the plate.  
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2 Antibodies 
2.1 Primary Antibodies 
 
For the immunochemical studies the following antibodies were used: 
• Caveolin-1 antibody (N-20) (rabbit). Santa Cruz Biotechnology Inc. 
(USA); 
• GAPR-1 antibody (α-1852) (rabbit). (Eberle, H. PhD Thesis); 
• Nucleolin antibody (mouse). Santa Cruz Biotechnology Inc. (USA); 
• Actin antibody (rabbit). Sigma Co. Saint Louis, MO. (USA); 
• p23 antibody against luminal domain of p23 (KAI2/3) (Sohn, K. et al. 
1996). 
2.2 Secondary Antibodies 
 
HRP-conjugated goat anti-rabbit IgG(H+L) and HRP-conjugated goat anti-
mouse IgG(H+L) were obtained from BioRad. HRP-conjugated Protein G 
Sepharose Beads was purchase from BioRad. 
3 Plasmids 
 
The following plasmids were used during this work various purposes as 
indicated below:  
pQE60  (Qiagen). GAPR-1 overexpression 
pbb131 (Duronio, R. J. et al. 1990). Expression of N-myristoyl 
transferase in E. Coli to acylate GAPR-1. 
pCDNA3.1(-/+)  (Invitrogen). GAPR-1 expression in mammalian cells. 
pEG202 (Kindly provided by Dr. Maribel Geli) Two Hybrid System. Fusion 
of GAPR-1 or Nucleolin to lexA (Bait plasmid) 
pJG4.5 (Kindly provided by Dr. Maribel Geli). Two Hybrid System. 
Fusion of GAPR-1 or Nucleolin to B42 (Prey plasmid) 
pEGFP-N1 (Invitrogen). GAPR-1 fusion with Green fluorescence Protein 
(GFP) or Nucleolin fused to GFP (Dr. J. A. Borowiec, NYU, 
School of medicine, New York, USA) 
pIRES2-EGFP (BD Biosciences). Bicistronic plasmid for simultaneous 
expression of GAPR-1 and GFP. 
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pKG-NUC (Kindly provided by Dr. Ahamed Saleem and Dr. Eric Rubin 
(Haluska, P. et al. 1998) containing full length Nucleolin fused to 
GST. 
4 Oligonucleotides 
The oligonucleotides used in this thesis were synthesized by NAPS 
(Goettingen) (HPLC grade). All oligonucleotides were solubilized in sterilized 
water to a final concentration of 100µM. All sequences are presented in table 
6. 
 
Designation Sequence ( 5’-3’) Purpose 
p17-2-hy1 AAACCAGAATTCATGGGCAAGTCAGCTTCCA 
p17-2-hy2 AAACCACTCGAGTTACTTCTTCGGCGGCAG 
NCL-2-hy1 AAACCAGAATTCATGGTGAAGCTCGCGAAG 
NCL-2-hy2 CCACCGCTCGAGCTATTCAAACTTCGTCTTCTTTCCTT 
Two Hybrid 
system 
(THS) 
PEG1 CGTCAGCAGAGCTTCACCATTG 
PJG1 CTGAGTGGAGATGCCTCC 
Sequencing 
of  THS 
constructs 
MUT1 AAGCACAGCCCGGAGTCCAGCCGTGGCCAGTGTGGGGCTAAC 
MUT2 GTTAGCCCCACACTGGCCACGGCTGGACTCCGGGCTGTGCTT 
Mutation: 
substitution 
GLU65 to 
ALA65 
MUT3 ACGAGGATCCTCAAGGCTAGCCCGGAGTCCAGCCGTGGC 
MUT4 GCCACGGCTGGACTCCGGGCTAGCCTTGAGGATCCTCGT 
Mutation: 
substitution 
HIS54 to 
ALA54 
MUT5 GAGGTGGCTGATAGATGGTACAGTGCTATCAAGAACTATACCTTCCAG 
MUT6 CTGGAAGTTATAGTTCTTGATAGCACTGTACCATCTATCAGCCACCTC 
Mutation: 
Substitution 
GLU86 to 
ALA86 
MUT7 GGCTTCACCTCGGGGACTGGAGCTTTCACGGCGATGGTATGG 
MUT8 CCATACCATCGCCGTGAAAGCTCCAGTCCCCGAGGTGAAGCC 
Mutation: 
Substitution 
HIS103 to 
ALA103 
52169N(1) GGGCTTCTTCGAAGAAAACGTCCTGCCGAAGAAGTAAAGATCTC 
52170N(2) GAGATCTTTACTTCTTCCGCGGGACGTTTTCTTCGAAGAAGCCC 
cutting site 
for SacII at 
GAPR-1 
C-terminus
 
Table 6. Oligonucleotides used to prepared constructs for the two hybrid system, site-directed 
mutagenesis of GAPR-1, and for GAPR-1 fusion to GFP. 
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5 Equipments 
 
PCR cycler was from ThermoHybaid, ultra-centrifuges were from either 
Beckman or Kontron Instruments (Watford, UK). Other centrifuges were from 
either Eppendorf or Heraeus. All rotors, including SW28, SW41, SW50, 
SW60, JA12.500, and TLA45 were from Beckman. Electrophoresis system, 
including plates, spacers and combs, and blot systems, including semi-dry 
trans-blot and wet blot were from Bio-Rad (Munich, Germany) or Invitrogen 
(Karlsruhe). Cell incubators were from Heraeus.  
 
Methods  
6 Methods in Cell Biology and Immunology  
6.1 Cell culture 
 
Chinese Hamster Ovary Cell (CHO) wild type, either adherent (monolayer) or 
in suspension, were grown in α-MEM medium supplemented with 10% Fetus 
Bovine Serum, L-glutamine and 10 mg/ml of penicillin and streptomycin and 
maintained at 37°C, 95% relative humidity in a 5% CO2 incubator (Heraeus). 
Rat Kidney fibroblast (NRK) as well as cervical carcinoma (HeLa) cells were 
maintained in DMEM medium, supplemented as indicated above for α-MEM. 
To check for viability in the spinner culture, the cells were counted using a 
Neubauer chamber, after treatment with a solution of Trypan blue to a final 
concentration of 0.3%.  
 
6.1.1 Passing of cells 
 
Cells growing as a monolayer (CHO, NRK, and HeLa) were split after 
reaching confluency. 10 ml of media were used to resuspend cells from a 10 
cm plate (around 5 x107 cells), and 1 ml of cells were transferred into a new 
10 cm plate containing 9 ml of fresh growth media. Cells were incubated at 
37°C in an incubator, as described above. 
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6.1.2 Culture of CHO and HeLa cell in suspension 
 
Four plates (10 cm) of confluent CHO or HeLa cells were washed once with 
PBS, followed by trypzination. The cells were resuspended in medium and 
transferred to a 1.5 L Spinner bottle containing 500 ml of α-MEM (CHO) or 
DMEM (HeLa). The bottles were placed into the incubator, and the medium 
was continuously swirled until cells reached 5-6 x105 cells/ml. Additional 
medium was added to dilute the cells 3 to 4 times and the cultures were 
incubated until they reached confluency. Cells were centrifuged at 500 xg 
using a preparative centrifuge (Heraeus).  
6.1.3 Transfection of cells 
 
Transfection procedures were conducted according to manufacturer’s guide 
(Invitrogen) with minor modifications. In each transfection, 1.5 µl of 
Lipofectamine™ 2000 and 1 µg of plasmid DNA were used for one well of a 6-
well plate (5 µl and 5 µg for a 5 cm dish, respectively).  One day before 
transfection, cells were plated in normal growth media so that they were 60% 
confluent at the time of transfection. For transfection, in different tubes the 
appropriate amount of plasmid and Lipofectamine™ 2000 were diluted in 100 
µl of Opti-MEM® reduced medium. After incubation at room temperature for 5 
min, the two diluates were combined (200 µl in total) and mixed gently by 
pipetting or shaking. The mix was incubated for 30 min at room temperature, 
followed by the addition of 0.8 ml of Opti-MEM® I reduced medium and gentle 
mixing. All mixtures were applied to cells pre-washed first with PBS, and Opti-
MEM® I reduced medium respectively. The solution was spread evenly over 
the plate by gently shaking or by rocking back and forth. The plates were 
incubated at 37°C in a CO2 incubator for 3 – 5 hrs. After incubation, 2 
volumes of normal growth media were added and cells were placed in the 
incubator. Cells were analyzed by immunoflourescence. 
6.1.4 Isolation of Primary Hepatocytes 
 
The isolated liver was preperfused in a non-recirculating manner with about 
250-300 ml of a Ca2+ -free Krebs-Henseleit bicarbonate medium (NaCl 119  
mM; KCl 4.7 mM; MgSO4 1.2 mM; KH2PO4 1.2 mM; NaHCO3 25 mM, pH 7.4 
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at 37o C when equilibrated with 95% O2 : 5% CO2 and glucose 11 mM. The 
buffer was equilibrated with 95% O2:5%CO2 before adding NaHCO3), and 
then perfused by recirculating 100 ml of the medium to which 2.5 mM CaCl2 
and 0.05% collagenase were added. Preperfusion and collagenase 
recirculation both lasted for about 10 min after which time tissue dissociation 
was normally completed. The softened tissue was resuspended in 50 ml of 
recirculation medium, cut into about 10 pieces and incubated in a 250 ml 
siliconized round bottom flask for 10 min at 37oC in a shaking water bath. The 
cells were successively sieved through three layers of Nylon of 250, 100, and 
60 µm pore size and were washed and isolated by centrifugation at 20 xg for 
3 min in a refrigerated centrifuge (Heraeus). The cell preparation was finished 
normally within 1 h. As tested by their ability to exclude trypan blue (0.3% final 
concentration) the viability of the hepatocytes obtained by this technique was 
95%. After 2 days, the cells were transfected with appropriated plasmid.  
  
6.2 Synchronization of mammalian cells 
6.2.1 Synchronization of mammalian cells by serum starvation 
CHO cells were grown in α-MEM supplemented with fetal bovine serum until 
they reached 80-90% confluency in 10 cm plates. At this point, the medium 
was removed, and plates were washed 2 times with sterile PBS. The medium 
was replaced by serum free α-MEM, and the cells were incubated for 3 hrs, 6 
hrs, 9 hrs, 24 hrs or 48 hrs in a CO2 incubator at 37oC. After incubation, the 
cells were harvested after homogenized (as indicated in part 6.4 of Material 
and Methods) to obtain total membranes. A protein determination (Lowry) was 
carried out for all the samples, and 25 µg of protein were loaded on a 14% 
gel. After separation of proteins by SDS-PAGE, and transfer to a PDVF 
membrane by western blot, the blots were analyzed for the presence of 
Caveolin-1, GAPR-1 and Actin by use of α-Caveolin-1 (Santa Cruz 
Biotechnology Inc.), GAPR-1 (α-1852) and α-Actin (Sigma Co.) antibodies, 
respectively. The signal on X-ray films of detected proteins were determined 
by Quantity One® software (BioRad).  
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6.2.2 Synchronization of mammalian cells by drugs  
CHO cells grown on 10cm plates with 80-90% of confluency were incubated 
in serum-free α-MEM medium for 48hrs to enrich the culture in cells 
predominantly in the G1 phase of the cell cycle. Alternatively, cells in G1 were 
enriched after treatment with 50 µM Lovastatin (Sigma Co.) for 24 hrs or 48 
hrs. CHO cells were enriched in the S phase by incubation with serum-free α-
MEM medium for 24 hrs, followed by addition of aphidicolin (Sigma Co.) (2 
µg/ml). After incubation for 20 hrs in the presence of aphidicolin, cells were 
incubated for 3 hrs in complete medium in the absence of aphidicolin. CHO 
cells were arrested in G2/M phase of the cell cycle by incubation in complete 
α-MEM medium containing 0.8µg/ml of nocodazole (Sigma Co.) for 16-20 hrs. 
 
6.2.2.1 Propidium Iodide Staining and Flow Cytometry 
Propidium iodide (PI) staining together with flow cytometry was used to 
determine the degree of cell synchronization in CHO cells. Treated cells (at a 
density of 1x106 cells) were washed with 2 ml of PBS and then digested with 
1ml of trypsin solution at 37oC for 5min. Cells were harvested by spinning 
down at 1200 rpm for 5min, followed by washing twice with 1ml of cold PBS 
(1ml). The pellet cells were resuspended in 1 ml fridge-cold 70% ethanol while 
vortexing the cell pellet gently, and then kept on ice for 30 min. Once in 
ethanol, samples could be kept for up to two weeks. Fixed cells were spun 
down at 2000 rpm for 5 min to remove ethanol and washed twice with 1ml 
PBS. The pellet was resuspended in 1ml PBS containing RNAse (100 µg/ml), 
and incubated for 5 min at room temperature. 400µl of propidium iodide (50 
µg/ml in PBS) were added to the cell suspension. Cells were stored in the 
dark for 30 min at room temperature and analyzed by flow cytometry. 
6.3 Immunofluorescence microscopy 
Indirect immunofluorescence was carried out according to standard 
procedures. Cells on cover-slips were washed twice in cold PBS and fixed 
with methanol at -20°C for 30 seconds. Cells were subsequently blocked in 
PBS containing 2% bovine serum albumin for 1 hr at room temperature or 
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overnight at 4°C. Permeabilization was achieved during the methanol fixation. 
For double labeling, cells were incubated with rabbit antibodies against 
GAPR-1 (1:2000) and mouse antibodies against GM130 (1:500). Primary 
antibody labeling was then visualized by incubation with Alexa Fluor® 488 
anti-rabbit IgG (1:1, 000) and/or Alexa Fluor® 568 anti-mouse IgG antibodies 
(1:1000). A Zeiss LSM510 flourescence microscope with appropriate filters 
was used. Images were collected and processed with LSM510 software. 
6.4 Phosphorylation of GAPR-1 in vivo 
CHO cells were cultured in 10 cm plates until they reached 80-90% 
confluency. After washing using HEPES buffer 50 mM pH7.5, the culture 
medium was replaced by 4 ml of phosphate free α-MEM or DMEM (Sigma 
Co.), containing HEPES at a final concentration of 20 mM (This allowed the 
cells to be incubated outside a CO2 incubator).1 mCi final concentration of 
H3PO4 (ortho-phosphate 32P) was added to the plates, and incubated for 4 hrs 
at 37oC. The medium was carefully removed from the plates, and the cells 
were washed twice by using cold PBS, and then harvested by using a rubber 
policeman (Cell Scraper). The cells were collected by centrifugation at 500 xg 
for 10 min. Lysis of cells was carried out by passing them through a 27G 
needle. 90% or more of the cells were broken as determined by trypan blue 
staining. The lysate was centrifuged at 500 xg for 10min, and the post-nuclear 
supernatant (PNS) was collected.  PNS, containing cytosol and total 
membranes, was centrifuged 1hr at 100000 xg. The sample was separated in 
pellet (total membranes) and supernatant (cytosol). The pellet (total 
membranes) was resuspended in 0.1 ml of 1% SDS, Tris-HCl 50 mM, pH 6.8, 
and heated to 95oC for 5 min. SDS was quenched by diluting with 0.9 ml of 
immunoprecipitation (IP) buffer (PEN buffer, containing 1% Triton X-100). The 
solubilized total membranes and cytosol were used for subsequent 
immunoprecipitation. Immunoprecipitation was carried out using a α-GAPR-1 
antibody (α-1852 R2), coupled to Sepharose 4B beads (see below). The 
antibody-beads were incubated with either the solubilized membranes or 
cytosol overnight at 4oC. After incubation, the beads were washed twice with 
PEN buffer containing 1% TX-100, and 4 times wash with PEN buffer, 
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respectively. The washed beads were resuspended in 15 µl of SCI and 15 µl 
SCII, incubated for 2 min at 95o C, and centrifuged at 14000 rpm for 30 
seconds. The supernatant was loaded onto a 14% gel, and proteins were 
analyzed by SDS-PAGE and western blotting. To analyze for the presence of 
GAPR-1 in the immunoprecipitate, the membranes were incubated with α-
GAPR-1 as primary antibody (same used for IP) and HRP-Protein G 
conjugated as a secondary antibody. After analysis, the membrane was 
washed several times in PBS-T buffer. To analyze the presence of 
phosphorylated GARP-1, the dried membrane was exposed to an X-ray film 
for autoradiography. 
6.5 Immunoprecipitation 
 
10µl of polyclonal serum against the C-terminus of GAPR-1 (α-1852) or 10 µl 
of Caveolin-1 antibody (Santa Cruz Biotechnology Inc. USA) were incubated 
with 50 µl of protein A Sepharose (Fast Flow, Amersham Pharmacia Biotech, 
Freiburg, Germany) and 50µl of PBS containing 0.5% milk for 90 minutes at 
RT. The beads were washed twice with PBS and twice with IP buffer (PEN 
buffer containing 1% TX-100) before use. Golgi membranes (500 mg) were 
centrifuged (100,000 g for 30 minutes at 4°C), and the pellet was 
resuspended in 100 µl 1%SDS and incubated for 5 minutes at 95°C. The 
sample containing denatured proteins was diluted with 900 µl of PEN 
containing 1% TX-100 and used for immunoprecipitation of GAPR-1 or 
Caveolin-1 by incubation overnight at 4°C with the protein-A beads. 
Subsequently the beads were washed twice in PEN buffer containing 1% TX-
100 and four times in PEN before analysis. For western blot analysis, a HRP-
protein G conjugate (BioRad) was used that does not recognize the denatured 
IgGs on the blot that were eluted from the beads used in immunoprecipitation. 
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7 Methods in Molecular Biology 
7.1 Polymerase Chain Reaction (PCR)   
7.1.1 Polymerase chain reaction (PCR) for site-directed 
mutagenesis 
 
All reactions were carried out according to the manufacturer’s guidelines. The 
reaction volumes were 50 µl, using the PfuTurbo polymerase (Stratagene). 
The reaction mix contains the following components: 5 µl of 10 X reaction 
buffer (Stratagene), 2 µl (10ng) of pQE60 plasmid carrying GAPR-1, 1.25 µl of 
each oligonucleotide (100 ng/µl), 1 µl of dNTPs (0.2mM), 1 µl of PfuTurbo (2.5  
U/µl), and MilliQ water to adjust the total volume to 50 µl. The PCR reaction 
was initiated with 1 cycle at 95°C for 30 sec, followed by 18 cycles starting at 
95oC for 30 sec, 55oC for 1 min, and 68oC for 11 min. 
7.1.2 Polymerase chain reaction (PCR) for Two Hybrid System  
 
Similar as mentioned above, the reaction volumes were 50 µl, using the 
polymerase PfuTurbo (Stratagene). The PCR reaction was initiated from 
denaturation at 95°C for 2 min, followed by denaturation at 94°C for 30 – 60 
sec. The annealing reaction was performed at appropriate temperatures 
(based on different primer pairs designed for the two hybrid assay (Table 6, 
section 4), in principle 10 - 15°C lower than the Tm of 55oC for 30 – 60 sec. 
Elongation was performed at 68°C for 3 min for Nucleolin (Nucleolin fragment 
is 2.1 kB) and for 1 min for GAPR-1 (GAPR-1 fragment is 0.5kb) (PfuTurbo 
amplified at 2 min/kb) and stopped at 68oC for 10 min for both Nucleolin and 
GAPR-1. In all cases, the reactions were performed for 30 cycles in the 
conditions indicated above. 5µl of PCR products were analyzed by agarose 
gel electrophoresis to ensure efficient amplification. Then, the PCR amplified 
fragments were purified from agarose gel slices with the use of Nucleobond 
extract kit (QIAGEN). Doubly digested plasmid vectors were also purified with 
this kit. Purified PCR products were either directly used for cloning into 
pJG4.5 or pEG202 after digestion with restriction enzymes (double enzyme 
digestion) or treated with DpnI in the case of site-directed mutagenesis 
products (in oder to digest the methylated, nonmutated parental DNA 
template). If the two used enzymes could not work in the same buffer, the 
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digestion mixtures were purified from gel, and the digestion repeated for the 
second enzyme.  
 
7.1.3 Subcloning 
 
All ligation reactions were carried out in 10 µl at either 4°C. The reaction mix 
contains 1 X ligation buffer (MBI Fermentas), 50 ng of DNA fragment, 25 ng of 
vector pJG4.5 or PEG202, and 2U of T4 DNA ligase (MBI). 5 µl of ligation 
mixtures were used to transform competent cells, either XL-1 Blue 
(Stratagene) for site-directed mutagenesis, or SURE super-competent cells 
(Stratagene) for the Two Hybrid assay, by heat-shock. Briefly, 50 µl of 
competent cells were mixed gently with 5 µl of ligation mixtures and incubate 
on ice for 30 min. The cells were heat-shocked at 42°C (XL-1 Blue and SURE 
super-competent cells) for 30 sec, followed by incubation on ice again for 2 
min. 1ml of pre-warmed medium was added to the transformation mixtures 
and incubated at 37°C for 1 hr with shaking. Cells were plated on LB agar 
plate containing appropriate antibiotics and incubated at 37°C overnight. 
Several colonies were randomly picked and inoculated into 4 ml of LB media 
supplemented with appropriate antibiotics. The cultures were incubated at 
37°C for 16-18 hrs. Plasmid DNA extraction was done using QIAgen miniprep 
kit or Machery-Nigel nucleospin kit. The protocol of these two kits is basically 
the same (modified alkaline lysis). Briefly, cells were pelleted by centrifugation 
at 4000 rpm 4°C for 10 min, and resuspended in 0.2 ml of solution I containing 
RNase. Cells were lysed by adding 250 µl of solution II, followed by mixing 
carefully the solution (upside-down movement for several times. The lysates 
were neutralized by the addition of 300 µl of solution III. The solution was 
cleared by centrifugation, and supernatants were loaded onto the binding 
column and spun down. The flow-through was discarded, and the columns 
washed with buffer PB and PE as indicated by the manufacturer. In the last 
wash, centrifugation was performed for 2 min to remove traces of ethanol. 
The plasmids were eluted with 50 µl MilliQ water sterile. All recombinant 
plasmids were identified by digestion with appropriated enzymes and 
confirmed by commercial DNA sequencing (Medigenomix GmbH). 
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7.1.4 Lithium acetate transformation of EGY48-pSH18-34 
 
To carry out the two hybrid assay, it was necessary to transform the yeast 
strain EGY48-pSG18-34, containing the galactosidase reporter, with the bait 
plasmid pEG202 and the prey plasmid pJG4.5.  The yeast was grown in 100 
ml SDC-URA medium to an optical density (OD) at 600nm of 0.4 - 0.8 units, 
equivalent to 1-2 x107 cells/ml, followed by harvesting the cells in a 50 ml 
tube. The cells were washed twice, by centrifugation at 4000 rpm for 10 min, 
with 15 ml of Li-TE buffer containing 10 mM Tris-HCl pH7.5, 1 mM EDTA, and 
100 mM lithium acetate (Li) adjusted to pH7.5 with acetic acid. The pellet was 
resuspended in 0.5 ml of Li-TE, and left at room temperature while preparing 
the DNA. For each transformation, 3-5 µl of carrier DNA 10 mg/ml (Herring 
Sperm DNA, Clontech) were mixed with 1 to 2 µg of plasmid DNA, 50 µl of 
cells and 150 µl of a 50% (w/v) polyethyleneglycol (PEG) solution (50g of 
PEG3500 dissolved in 100ml of TE buffer). The mix was vortexed by 5 pulses 
at full speed. The suspension was incubated for 30 min at room temperature, 
followed by incubation at 42oC for 15 min, and then 200 µl of TE were added 
to the incubation.  The samples were plated on the appropriate minimal 
media.   
 
Table 7. List of transformations carried out in EGY48-pSH18-34 to determine a GAPR-1 
interaction with Nucleolin or GAPR-1 
 
GAPR-1wt-pEG202 (pEGGAPR-1wt) Nucleolin-pJG4.5 (pJGNCL) 
GAPR-1wt-pJG4.5 (pJGGAPR-1wt) Nucleolin-pEG202(pEGNCL) 
GAPR-1mut-pJG4.5(pJGGAPR-1mut) Nucleolin-pEG202(pEGNCL) 
GAPR-1mut-pEG202 (pEGGAPR-1mut) Nucleolin-pJG4.5 (pJGNCL) 
GAPR-1wt-pEG202 (pEGGAPR-1wt) Nucleolin-pEG202(pEGNCL) 
GAPR-1wt-pJG4.5 (pJGGAPR-1wt) Nucleolin-pJG4.5 (pJGNCL) 
GAPR-1mut-pEG202 (pEGGAPR-1mut) Nucleolin-pEG202(pEGNCL) 
GAPR-1mut-pJG4.5(pJGGAPR-1mut) Nucleolin-pJG4.5 (pJGNCL) 
GAPR-1wt-pEG202 (pEGGAPR-1wt) GAPR-1wt-pJG4.5 (pJGGAPR-1wt) 
GAPR-1wt-pEG202 (pEGGAPR-1wt) GAPR-1mut-pJG4.5(pJGGAPR-1mut) 
GAPR-1mut-pEG202 (pEGGAPR-1mut) GAPR-1mut-pJG4.5(pJGGAPR-1mut) 
GAPR-1wt-pJG4.5 (pJGGAPR-1wt GAPR-1mut-pEG202 (pEGGAPR-1mut) 
Possible 
interactions 
analyzed by 
the two 
hybrid 
system 
assay. 
GAPR-1wt-pJG4.5 (pJGGAPR-1wt) GAPR-1wt-pJG4.5 (pJGGAPR-1wt) 
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GAPR-1wt-pEG202 (pEGGAPR-1wt) GAPR-1wt-pEG202 (pEGGAPR-1wt) 
Nucleolin-pEG202(pEGNCL) Nucleolin-pJG4.5 (pJGNCL) 
Nucleolin-pJG4.5 (pJGNCL) Nucleolin-pJG4.5 (pJGNCL) 
Nucleolin-pEG202(pEGNCL) Nucleolin-pEG202(pEGNCL) 
GAPR-1wt-pEG202 (pEGGAPR-1wt) empty vector pJG4.5 
empty vector pEG202 GAPR-1wt-pJG4.5 (pJGGAPR-1wt) 
GAPR-1mut-pEG202 (pEGGAPR-1mut) empty vector pJG4.5 
GAPR-1mut-pJG4.5(pJGGAPR-1mut) empty vector pEG202 
empty vector pEG202 empty vector pJG4.5 
Controls 
designed for 
the two 
hybrid 
system 
assay. 
 
8 Methods in Biochemistry 
8.1  Isolation of Golgi membranes 
8.1.1 Golgi membranes  from CHO cells 
 
Solutions: 
EDTA stock solution 100 mM EDTA/KOH pH7.1 
Homogenization buffer 250 mM Sucrose 
       10 mM Tris-HCl pH7.4 
Sucrose Solutions    29%(w/w) Sucrose in 10 mM Tris-HCL pH7.4 
      35%(w/w) Sucrose in 10 mM Tris-HCL pH7.4 
      62%(w/w) Sucrose in 10 mM  Tris-HCl pH7.4 
 
Golgi membranes were prepared as described previously (Balch, W. et al. 
1984; Malhotra, V. et al. 1989; Serafini, T. et al. 1991). One preparation of 
Golgi membranes from CHO requires 10 L of cultured cell with a density of 
7x105cells/ml approximately. CHO cells were harvested at 500 xg and washed 
twice in cold PBS. The pellet was further washed with cold homogenization 
buffer. The wash steps were conducted at 1,500 xg for 10 min. The pellet was 
resuspended in 5 volumes of cold homogenization buffer, followed by 
breaking of the cells with the Balch homogenizer. 50-60 strokes were needed 
to disrupt more than 90% of the cells. To 12 ml of homogenate, 11 ml of 62% 
(w/w) sucrose solution was added and 250 µl of 100 mM EDTA (pH7.1). The 
sucrose concentration was determined by refractometer. If the sucrose was 
out of the range of 36.5-37.5% (w/w), it was adjusted by adding either 10 mM 
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Tris-HCL buffer (pH7.4) or sucrose solution. This adjustment was achieved by 
using the following formula: 
If more sucrose was needed, the volume of 2 M sucrose solution in 10 mM 
Tris-HCl pH7.4 necessary was calculated: 
 
Voriginal X (Cwanted – Coriginal)   = Vto add 
(Cstock solution – Cwanted) 
 
If less sucrose was needed, the volume of 10 mM Tris-HCl pH7.4 was 
calculated: 
 
Voriginal X (Cwanted – Coriginal)   = Vto add 
(Cwanted) 
 
 
Voriginal = Volume of homogenate solution after adding 62% (w/w) 
sucrose; 
Vto add = Volume to add of either 2M sucrose solution or 10 mM 
Tris-HCL    buffer. 
Coriginal = Sucrose concentration of homogenate solution after 
adding 62% (w/w) sucrose. 
Cwanted = Desire concentration of sucrose (i.e. 37% (w/w)) 
Cstock solution = Stock solution of Sucrose at 2 M 
 
 
After adjustment, the homogenate was transferred to a tube SW28 tube, and 
the following sucrose gradient was made: 12 – 14 ml of 37% (w/w) sucrose-
homogenates at the bottom, followed by 15 ml of 35% (w/w) overlaid carefully 
on the homogenate, and 9 ml of 29% (w/w) sucrose on the top. The gradient 
was centrifuged at 4°C 25,000 rpm for 2.5 hrs. The Golgi membranes floated 
as an opalescent band at the interface between 29% and 35% while ER 
fraction at the interface between 35% and 37%. Golgi fractions were collected 
as much as 2 – 3 ml for each gradient and all the fractions were combined. 
Separated aliquots of 200 µl to 500 µl were stored at 4°C for protein 
determination. The rest of the aliquots were frozen in liquid nitrogen and 
stored at -80°C. 
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8.1.2 Isolation of Golgi membranes from rat liver 
 
Solution Buffers I  10 mM Tris-HCL pH7.4 0.5 M Sucrose 
    100 mM EDTA pH7.4 
Sucrose Solutions:  30.5% (w/w) Sucrose in 10 mM Tris-HCl pH7.4 
    35% (w/w) Sucrose in 10 mM tris-HCl pH7.4 
    37% (w/w) Sucrose in 10 mM Tris-HCl pH7.4 
 
The liver from a rat was removed and based on its weight 4 times in buffer I 
was added, and the EDTA concentration was adjusted to 5mM final 
concentration. The tissue was minced using scissors and then homogenized 
on ice with a Dounce homogenizer. The homogenate was centrifuged at 2500 
rpm for 10min, and the post nuclear supernatant (PNS) was filtered through 4 
layers of cheesecloth. In a SW28 rotor tube, 30 ml of PNS were added and 
overlaid on 8 ml of 37% (w/w) sucrose solution. The sample was centrifuged 
at 25000 rpm (83000 xg) for 1.5 hrs.  A band was collected at the interface 
37% - 16% (w/w) of sucrose, and 4 ml were collected per sample. The 
sucrose concentration was adjusted to 37% (w/w) using either a 55% (w/w) 
sucrose solution or 10 mM Tris-HCl pH7.4 (see formula on section 9.1.1). 14 
ml of membranes adjusted to 37% (w/w) sucrose were poured into a SW28 
tube, and overlaid with 10 ml of 35% (w/w) sucrose, followed by a 10 ml layer 
of 30.5% (w/w) sucrose, and 5 ml of 25% (w/w) sucrose. The gradient was 
centrifuged at 25000 rpm (100.000 xg) for 2.5 hrs, and the Golgi membranes 
collected at the interface 25% - 30% (w/w) sucrose. The membranes were 
fractionated in aliquots and frozen at -80oC.  
  
8.1.3 Preparation of Golgi-derived detergent insoluble complexes 
(GICs) 
 
Golgi-derived microdomains were prepared as described by Gkantiragas, I. et 
al. (2001). 7 mg of Golgi membranes were collected by centrifugation at 4°C 
100,000 xg for 1 hr after dilution with 4 volumes of PEN buffer. The pellet 
(Golgi membranes) was resuspended in 2 ml of ice-cold PEN buffer 
containing 1% TX-100, followed by incubation on ice for 30 min.  2 ml of 80% 
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(w/v) sucrose in PEN buffer (without Triton X-100) were added to the 
resuspended membranes to obtain a 40% solution. The mixture was 
transferred into a SW41 tube and sequentially overlaid with 1.3 ml of the 
following sucrose solutions: 30%, 25%, 20%, 15%, 10% and 5% sucrose 
(w/v). The gradient was centrifuged for 22 hrs at 4°C 39,000 rpm, and the 
opalescent band at the interface between 10% and 15% was collected. An 
aliquot was used for protein and lipid quantification and the other aliquots 
were at -80°C. 
9 Cytosol preparation from Mammalian Cells 
9.1 Cytosol preparation from CHO and Hela Cells 
 
CHO or HeLa cells were cultured in suspension as indicated in section 8.1.1. 
1.2 L of suspension cultures were spun down at 500 xg for 10min. The pellet 
was washed twice with PBS, and then washed twice with breaking buffer 
containing 10 mM Tris-HCl, pH7.5, 0.25 M sucrose, followed by dilution 1:5 in 
breaking buffer (1.2 L of suspension culture yields approximately 5ml of cell 
pellet). The suspension was homogenized as described in section 8.1.1., and 
the homogenate was adjusted to a concentration of 0.5 M KCl, and incubated 
for 1 hr on ice for 30 min. After incubation, the homogenate was centrifuged 1 
hr at 55000 rpm (TFT rotor 55.38). The supernatant was dialyzed once 
against 5 L of PBS, and twice against 50 mM Tris-HCl pH7.5, 50 mM NaCl. 
The dialyzed cytosol was centrifuged at 100000 xg for 2 hrs. 
 
9.2   Cytosol preparation from Rat liver 
 
Solution buffer H:  165 mM KOH 
       50 mM HEPES pH7.55 (Acetic acid) 
         2 mM MgCH3CO2 
Additional components:      1 mM DTT 
(protease inhibitors Solution)  1 µM Leupetin 
       10 µM Antipain 
      100 µM PMSF 
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9 g of rat liver from 1.5 months old rats were blended following 
homogenization by a Dounce homogenizer in buffer H and addition the 
protease inhibitor solution. The homogenate was centrifuge at 9000 rpm for 
10 min. The pellet was discarded and the supernatant was subjected to 
another round of centrifugation using a TFT rotor (55.38) in a Kontron 
centrifuge at 33000 rpm (100000 xg) for 1 hr. The supernatant was collected 
and centrifuged again in TFT rotor (55.38) at 44000 rpm (160000 xg) for 1.5 
hrs. The supernatant was divided in aliquots and frozen at -80oC.  
9.3 Cytosol fractionation 
 
A 320 ml Superdex200 prep grade (Amersham Biotech) column was 
calibrated by loading proteins with known molecular masses, such as 
Thyroglobulin (669kDa) Alcohol Dehydrogenase (150kDa), Bovine Serum 
Albumine (66kDa), Carbonic Anhydrase (29kDa) and lysozyme (14kDa) and 
determination of the elutions pattern and fraction locations in a Biologic 
workstation (BioRad). To fractionate cytosol of either CHO or HeLa, 10 ml of 
cytosol containing 20 mg/ml protein were loaded on the pre-equilibrated 
Superdex200 column. The eluted fractions were separated in a low molecular 
weight fraction containing proteins below 100kDa (LMW) and a high molecular 
weight fraction containing proteins above 100kDa (HMW). Both fractions were 
about 200 ml, and were separately loaded onto a GAPR-1 affinity column to 
determine whether GAPR-1 binds to a complex of proteins in the cytosol 
bigger than 100kDa or smaller than 100kDa.   
 
9.4  Cytosolic Protein complex denaturation 
 
200 ml of HeLa cytosol at 1mg/ml were subjected to denaturation by adding 
1% SDS followed by incubation at 95oC for 20min.  The denaturated solution 
was quenched by adding 1,8 L of buffer containing Tris-HCl 50 mM pH7.5, 50 
mM NaCl, 1% Triton X-100.  The solution was then loaded onto a GAPR-1 
affinity column, containing either GAPR-1 wild type or GAPR-1 mutant. 
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10 Large scale purification of GAPR-1  
 
GAPR-1 was over-expressed in M15[RP4] bacteria, containing a GAPR-1-
pQE60 vector.  An overnight culture was prepared in LB medium containing 
100 µg/ml ampicilin (AMP) and 50 µg/ml kanamycin (KAN). 12 L of LB 
medium, containing AMP and KAN, were inoculated with 30 ml of overnight 
culture, and incubated until an optical density at 620nm of 0.5 was reached. 
The overexpression was induced by the addition of 12 ml of 1M IPTG, and the 
incubation was continued for 3 hrs at 37oC. The 12 L suspension were 
centrifuged at 7000 rpm for 10 min (preparative centrifuge, Hereaus), and the 
pellet resuspended in DEAE buffer containing 50 mM Tris-HCl pH7.5 and 50 
mM NaCl. The pellet was washed once in DEAE buffer and resuspended in 
300 ml of DEAE buffer containing a mix of protease inhibitors (tablets, 
Boehringer, Mannheim). The suspension was passed 5 times through a cell 
disruptor (Emulsiflex®, Avestin), or passed 3 times through a French press, 
and the homogenate was centrifuged at 4000 rpm for 15 min to remove 
unbroken cells. The supernatant was centrifuged at 100000 xg for 1hr (TFT 
rotor 55.38, Kontron Instruments). After centrifugation, supernatant was 
diluted ~1:6 in DEAE buffer, giving a total sample volume of approximately 1.8 
L. The 1.8 L sample was passed over a DEAE column (Amersham Biotech) 
(1ml/min) was equilibrated with 50 mM Tris-HCl pH7.5; 50 mM NaCl. The flow 
through was collected and applied onto a 25 ml cation exchange column 
(Macroprep High S support, BioRad), pre-equilibrated with DEAE buffer. The 
column was washed with DEAE buffer until the optical density at 280 nm was 
below 0.1. To elute the bound proteins from the column, a liner gradient from 
50 to 1000 mM NaCl was applied, and fractions of 1 ml were collected, after a 
dead volume of approximately 16 ml. Fractions containing highest and purest 
amount of GAPR-1 were combined (4 ml) and applied onto a Superdex200 
column 26 mm x 76 cm (Amersham Biotech) for further purification, collecting 
fraction of 2ml. The peak fractions were analyzed by SDS-PAGE (14% gel). 
For every step during the purification, samples were collected for analysis, 
and quality control of the purification process. For large a scale purification of 
GAPR-1 mutant, the same protocol was followed. GAPR-1 wild type, and 
mutant proteins purified by this protocol were used for further studies. 
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10.1 Size exclusion chromatography light scattering (SEC-LS) 
 
The molecular masses of GAPR-1 wild type and mutant proteins were 
determined using SEC-LS. 200 µl of GAPR-1 (200 µg/ml) was applied to a 
Superdex200 HR 10/30 (Amersham Biotech) upstream of DAWN DSP LS 
(Wyatt QELS). The column was equilibrated in Tris-HCl 50 mM pH8.0, 300 
mM NaCl at a flow rate of 0.5 ml/min. The average molecular masses (Mw) of 
GAPR-1 were calculated at peak maxima using three independent analyses, 
i.e. the two and three-detector method, and the ASTRA analysis. The Mw was 
estimated throughout the entire eluting peak at 50 µl intervals using ASTRA 
software. 
10.2 Crystal structure determination 
 
The following protocols were used by Dr. Matthew Groves and Audrey Kühn 
(EMBL) to obtain GAPR-1 crystal. Briefly, the protein products obtained from 
overexpression were checked by dynamic light scattering, mass spectrometry 
and equilibrium centrifugation for homogenity and oligomerisation state prior 
to crystallization.  The protein was concentrated using Amicon Centricon 
10kDa filters to a concentration of 12.6 mg/ml as estimated by Bradford 
reagent (BioRad).  Initial screening was performed at room temperature 
(295.5K) by hanging drop vapour diffusion (McPherson, 1982) using the 
sparse matrix kits from Hampton Research (Hampton Research, Laguna 
Niguel, CA).  Drops were prepared on siliconized cover slips and equilibrated 
against 1ml reservoir solution.  Screens were prepared by combining equal 
volumes of reservoir solution with protein solution.  Conditions producing 
crystals from the initial screens were refined to produce crystals suitable for X-
ray diffraction analysis. 
10.2.1 Data Collection 
 
After transferring to a cryoprotectant solution (reservoir solution with an 
additional 15% v/v glycerol), crystals were picked up using a fiber loop and 
flash frozen in a stream of nitrogen gas at 100K.  In-house diffraction data 
were collected from a single crystal on a Mar345 (Mar Research) image-plate 
detector using Cu Kα radiation from a rotating-anode X-ray generator 
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operating at 50kV and 100mA.  A higher resolution data set was collected at 
the ID14 EH-2 ESRF beamline on a MarCCD detector.  The programs 
MOSFLM (Leslie, A 1992), SCALA (Evans, P. 1997), SHARP (Fortelle, E. de 
la,. Bricogne, G. 1997), O (Jones, T. et al. 1991) and CNS (Brünger. A. et al. 
1998) were used for data processing and analysis. 
10.3 Circular Dichroism of GAPR-1 
 
CD spectra were recorded on a Jasco J720 spectrophotometer.  The 
instrument was calibrated with 10 mM sodium phosphate buffer. Cell path 
lengths 1 mm and 2 mm were used.  GAPR-1 wild type and mutant were 
dialyzed twice against 10 mM sodium phosphate buffer prior to measurement. 
Spectra were acquired at a scan speed of 100 nm/min with a 1-nm slit and 1-
second response time, averaging 20 scans, and corrected by subtraction of 
the solvent spectrum obtained under identical conditions. To carry out the Far 
U.V spectra measurements 5.8 µM of protein was used both GAPR-1 wild 
type and mutant, and for the Near-UV spectra measurements 588 µM were 
used, respectively.  
10.4 Coupling of GAPR-1 to CNBr-activated Sepharose 4B 
 
Swelling Buffer  HCl 1 mM cold 
Coupling buffer  NaHCO3 0.1 M, pH8.3; NaCl 0.5 M 
Blocking buffer  Ethanolamine 1 M pH8.0 
Washing buffer  Acetate buffer 0.1 M, pH4.0 
 
0.5g of CNBr-activated Sepharose 4B (Amersham Biotech) were washed and 
swelled 5 min in 300ml of cold HCl 1mM by centrifuging 5 times with 50 ml at 
1000 rpm. 5 mg of purified GAPR-1 (wild type or mutant) were dialyzed in 
coupling buffer prior to mixing with the swelled resin. The mix was incubated 
overnight at 4oC with gentle agitation, followed by centrifugation at 1000 rpm 
for 5 min. The supernatant was concentrated using amicon concentration 
units to 1 ml, and a protein determination was carried out to estimate the 
coupling efficiency.  The gel was transferred to a solution of ethanolamine (1 
M) to block the remaining active groups for 16 hrs at 4oC. The gel was 
                                                                                                  Materials and Methods 
 95
washed with coupling buffer followed by acetate buffer, and again coupling 
buffer to wash away excess adsorbed protein. The protein-coupled-agarose 
beads were ready to use at this point. 
11 GAPR-1 affinity Chromatography 
 
200 ml of CHO cytosol (1 mg/ml) were prepared (section 9.1) and loaded onto 
1ml GAPR-1 affinity columns, either GAPR-1wt or GAPR-1mut columns, at a 
flow rate of 0.5 ml/min. After loading, the columns were washed with wash 
buffer (Tris-HCl 50 mM pH7.5, 50 mM NaCl), and coupled to a SMART® 
FPLC system (Amersham Biotech). When the optical density at 280nm 
reached 0.05, a NaCl gradient 50-1000 mM was applied (0.5 ml/min) to elute 
the proteins bound to GAPR-1. The system collected 48 samples of 250 µl 
each. The fractions were analyzed by SDS-PAGE (Novex®, Invitrogen), and 
the protein composition of the samples was identified by mass spectrometry 
fingerprinting (MALDI-TOF). The columns were also used with HeLa cytosol 
and Rat liver cytosol. 
12 GAPR-1 Ligand Overlay 
 
50 µg of proteins from cytosol were separated by 12% SDS-PAGE (Novex® 
Invitrogen) and transferred to a nitrocellulose membrane (BA 85, Schleicher 
and Schuell). The proteins transferred to the membrane were renaturated by 
incubation at 4oC for 1 to 2 days in renaturation buffer containing 50mM 
HEPES/KOH pH7.2, 5 mM magnesium acetate, 100 mM potassium acetate, 3 
mM DTT, 10mg/ml BSA, 0.1% (w/v) triton X-100, and 0.3% (w/v) Tween 20. 
After renaturation, the membrane was incubated at room temperature for 1hr 
in binding buffer containing 12.5 mM HEPES/KOH, pH7.4, 1.5 mM 
magnesium acetate, 75 mM potassium acetate, 10 mM ZnSO4, 1 mM DTT, 2 
mg/ml BSA, 0.005% (w/v) triton X-100, 4 mM n-octylglycopyranoside, and 0.5 
µM of GAPR-1. The filter was then washed several times with washing buffer 
composed of 20 mM Tris-HCl pH7.4, 100 mM NaCl, 20 mM MgCl2, and 
0.005% Triton X-100. 
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After washing, the membrane was incubated with antibody against GAPR-1 
(α-1852) and developed using secondary antibody anti-rabbit HRP-
conjugated. 
13 SDS-PAGE and Western Blot analysis 
13.1 SDS-PAGE for separation of proteins 
Gels for SDS-PAGE were prepared according to the guidelines of Molecular 
Cloning (3rd ed.). 12% and 14% separation gels were used in this 
experimental work or 12% and 4-12% pre-cast separation gels commercially 
available from Invitrogen. After electrophoresis, the gels were stained in 
coomassie blue solution and destained. For radioactive gels, after staining, 
the gels were dried and exposed to a film. Other gels were used for western 
blot analysis of the proteins of interest. 
13.2 Transfer proteins from SDS-PAGE to a PVDF membrane or 
Nitrocellulose  
 
After performing SDS-PAGE, the proteins were electro-transferred to PVDF 
membranes (Immobilon-P® Milipore). The PVDF-membrane was submerged 
in methanol prior to soaking in the Anode buffer II. In semi-dry blotting 
discontinuous buffer system is used, composed of two anode buffers and one 
cathode buffer. The SDS-PAGE gel and PVDF membrane were arranged as 
follows: 2 sheets of Whatman 3MM filter paper pre-soaked in Anode buffer I 
were placed on the platinum anode, followed by 2 sheets of Whatman paper 
pre-soaked in Anode buffer II, the PVDF-membrane, the gel, and firmly 3  
sheets of Whatman paper pre-soaked in Cathode buffer on top. The air was 
removed carefully by rolling out the air bubbles either by using a pipette or a 
50ml tube. The cathode was placed on the stack and the blotting was 
executed at 24V for 1.5 hrs. 
13.3 Incubation of PVDF membranes with antibodies 
 
Once the transfer was completed, the PDVF membrane was rinsed in water 
and stained with a Ponseau S solution. Excess of Ponseau S dye was 
washed away with water until protein marker bands appeared on the 
membrane and their positions could be marked on the membrane. The 
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markers used throughout most of the thesis were broad range protein marker 
from Bio-Rad™. The size of the protein markers is outlined in Table 8. 
 
Table 8. Protein standards (Broad Range) 
Protein Molecular mass (kD) 
Myosin 200 
β-galactosidase 116 
Phosphorylase-b 97 
Serum albumin 66 
Ovalbumin 45 
Carbonic anhydrase 31 
Trypsin inhibitor 21 
Lysozyme 14 
Aprotinin 6.5 
 
 
The PVDF membrane was blocked with 50 ml of 5% BSA in PBS for 1 hr at 
room temperature or overnight at 4°C. The blot was rinsed for 1min in PBS to 
remove BSA and incubated with the diluted primary antibodies (in 1% BSA 
PBS-T) for 1 hr at room temperature, followed by washing  3 times with  PBST 
for 15 min. The blot was incubated with the HRP-conjugated secondary 
antibodies (1/1000 dilution) or HRP-conjugated Protein-G (1/1000 dilution) in 
50 ml 1% BSA in PBST for 1 hr at room temperature. The blot was washed 3 
times with PBST for 15 min and developed using ECL® western blotting 
detection system (Amersham-Biotech). 
14 Protein Determination 
14.1 Protein Determination by BCA 
 
For soluble protein determination the BCA protein assay was employed 
(Pierce). All samples, including a set of standards (BSA: 2.5 µg, 5.0 µg, 10 µg, 
15 µg, 20 µg, 25 µg, 30 µg and 35 µg), were prepared in aqueous solution.  
For 10 µl of each sample 200 µl of working reagent was added. The solution 
was prepared by mixing 50 parts of Reagent A with 1 part of Reagent B. The 
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samples, including standards and blanks, were incubated at 37°C for 30 min, 
followed by measurement of absorbance at 562nm on a plate reader. 
14.2 Protein determination by Lowry 
 
Lowry Solution A: 2 g Na2-tartrate Dissolved in 500 ml 1N NaOH,   
   100 g N2CO3   adjusted to 1 L with MiliQ water 
Lowry Solution B: 2 g Na2-tartrate Dissolved in 90 ml H2O, 10ml NaOH 
   1 g CuSO4x 5H2O adjusted to 500 ml with MiliQ water 
Lowry Solution C: Folin-Cicocalteus. Reagent prepared prior to use by  
      diluting 1/10 with MiliQ water 
 
Protein determination for membrane protein was performed according to 
Lowry. The protein standards were prepared with BSA (2.5 µg, 5.0 µg, 10 µg, 
15 µg, 20 µg, 25 µg, 30 µg and 35 µg) dissolved in water. The samples and 
standards were prepared by adding 10 µl of deoxycholate stock solution 
(Stock solution: Sodium deoxycholate 2 mg/ml) to 50 ul of sample. 150 µl of 
TCA (10%) (TriChloroacetic acid) were added to the sample, vortexed and 
centrifuged for 10 min at 14000 rpm. The supernatant was removed, and 10 µl 
of SDS were added, followed by 50 µl of Lowry solution A. The sample was 
incubated at 50oC for 10min, and cooled down for 3min to room temperature. 
10 µl of Lowry solution B was added, and the sample incubated for 15min at 
room temperature. 150 µl of Lowry solution C were added, and the sample 
was placed at 50oC for 10 min. Once the sample was at room temperature 
again, the absorbance was measured at 620nm on a plate reader. 
 
15 Protein Precipitation  
15.1 Chloroform-Methanol Precipitation 
 
Chloroform-Methanol Solution 1:2 20 ml CHCl3: 40 ml CH3OH 
 
One volume of sample was mixed with 3 volumes of Chloroform-Methanol 
solution. The mix was vortexed until the solution was clear (1 or 2 drops of 
methanol were added when the solution did not become clear). The sample 
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was centrifuged 14000 rpm for 15min at 15oC. The supernatant was discarded 
and the pellet was dried for 1hr at 37oC or overnight at room temperature. The 
pellet was dissolved by adding Sample cocktail I. Once dissolved, the sample 
was suitable for protein determination and/or protein electrophoresis. 
15.2 TCA precipitation  
 
TCA solution 72% (w/v) 72 g of trichloacetic acid dissolved in 100 ml H2O 
Sodium deoxycholate 2% 2 g of Sodium deoxycholate in 100 ml H2O 
Acetone   kept at -20oC 
 
The protein sample was diluted to a final volume of 1ml with MilliQ water, 
followed by addition of 16.7 µl of 2% sodium deoxycholate. The sample was 
vortexed and incubated for 15min at room temperature. 100 µl of TCA solution 
72% was added to the sample and vortexed, and then centrifuged for 7 min at 
14000 rpm. The supernatant was aspirated and 1ml of acetone at -20 added 
to wash the pellet. The sample was centrifuged as described above, and the 
pellet was allowed to dry. 
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